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Summary  
Neurological disorders contribute to 6.3% of the global burden of the diseases and this number is increasing every 
year due to aging population. Despite enormous efforts in brain and central nervous system related research, 
neurodegenerative diseases such as Alzheimer or Parkinson disease remain the world's leading cause of 
disability. Moreover, neurodegenerative diseases are multifactorial pathogenesis with a complex combination of 
genetic components and environmental factors. Although, several treatment methods are available to treat these 
conditions, they are associated with the risk of infection, high neurosurgical cost and limited drug availability due 
to the presence of blood–brain barrier (BBB). 
 
Herbal medicine for neurological problems has gained much attention in the recent years, because of the 
disadvantages of conventional therapies and increased patient compliance. Generally, the drugs obtained from 
natural sources are considered to be safe alternatives. Since ancient times, plant extracts have been used in the 
treatment of pathologic conditions of the central nervous system. As the methods to isolate active constituents 
from plant extracts have greatly improved, the scientific understanding of psychoactive plants has also advanced 
significantly. Curcuma species and Withania somnifera have been used as traditional therapeutic agents in Asian 
medicine to treat various common ailments and recently reported to possess antioxidant, antidepressant and 
neuroprotective effects. 
 
Although a number of herbal-based medicines have been screened and identified, still the treatment for the 
neurological disorders is not up to the required level. This is mainly because most of the herbal medicines exhibit 
poor bioavailability due to low absorption, fast metabolism, and rapid systemic elimination in the body. Although 
several approaches have been employed to overcome these problems, modification in the delivery method is a 
promising approach. In particular, employing herbal medicine based nanocarrier system to treat neurological 
disorder has gained specific interest because of its several advantages namely, the ability of nanoparticles to 
deliver the drug in a pre-determined rate at a particular site of action, providing high bioavailability and low toxicity. 
Compared to the conventional delivery methods, nanoparticle-mediated administration of drugs has been proven 
to be the ideal way to deliver drugs for neurological disorders. Due to these advantages, pharmaceutical scientists 
have started designing nanoparticle mediated drug delivery systems for herbal medicines with neurotherapeutic 
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potential. Nanoencapsulation of bioactive compounds and extracts into the polymer matrix gives several 
advantages, including protection against degradation, enhancing the solubility and bioavailability. 
 
In this PhD thesis we have selected two important medicinal plants with proven antioxidant, antidepressant and 
neuroprotective effects namely W. somnifera and Curcuma sps for nanoencapsulation and subsequent cellular 
uptake with U251 glioma cells and biodistribution analysis in Zebrafish model.  
First we developed HPLC methods to identify withanolides and quantify curcumin respectively from W. somnifera 
extracts and Curcuma species. Extracts derived from different parts (leaves, roots and fruits) of W. somnifera were 
tested. W. somnifera extract with maximum amount of withanolides and curcumin (active principle of Curcuma 
sps) were selected for nanoencapsulation. We found that Purospher RP-18 e 5 µm column is ideal for efficient 
separation and simultaneous quantification of withanolides whereas, Purospher C-18 column was optimum for 
curcumin quantification from Curcuma sps extracts. HPLC quantification of different extracts of W. somnifera 
revealed that the methanolic extract obtained from leaf tissues contain the highest amount of withanolides 
compared to roots and fruits. Compared to C. aromatica, C. longa possess higher amount of curcumin. 
 
W. somnifera extract/curcumin loaded polycaprolactone (PCL) and methoxy polyethylene glycol- polycaprolactone 
(MPEG-PCL) nanoparticles were prepared by solvent displacement method. Prepared nanoparticles were 
characterized for their physico-chemical properties such as size, shape, in vitro drug release and encapsulation 
efficiency. After the physico-chemical characterization, we analyzed the in vitro cytotoxicity and cellular uptake of 
nanoparticles by U251 glioma cells. In addition, we evaluated the protective effect of W. somnifera extract and 
curcumin loaded nanoparticles against tBHP-induced insult in U251 glioblastoma cells, as a measure of 
neuroprotection. Biodistribution of W. somnifera /curcumin loaded PCL and MPEG-PCL nanoparticles in animal 
system were evaluated using zebrafish larvae as model organism.  
Physical characterization of the prepared nanoparticles revealed that MPEG-PCL nanoparticles were smaller in 
size compared to PCL nanoparticles irrespective of W. somnifera extract or curcumin encapsulation. Transmission 
scanning electron microscopy (TEM) images of nanoparticles revealed a round shape in general, although the 
surface of PCL nanoparticles appeared to be rough and porous. The entrapment efficacy of W. somnifera extract 
and curcumin was higher in MPEG-PCL compared to PCL. We observed an initial burst release followed by a slow 
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extended release profile for both W. somnifera extract and curcumin irrespective of the polymer used for 
encapsulation.  
Treatment of U251 glioma cells with PCL and MPEG-PCL nanoparticles loaded with W. somnifera extract/ 
curcumin evidenced the efficient cellular uptake of nanoparticles. However, MPEG-PCL nanoparticles showed 
better internalization compared to PCL nanoparticles, irrespective of their W. somnifera extract/ curcumin load. 
Neuroprotection assay showed that both W. somnifera/ curcumin loaded nanoparticles protect the cells from 
oxidative damage. While the neuroprotective effect of W. somnifera extract increased in a dose dependent 
manner, curcumin was much effective in lower concentrations. Together, our results show that W. somnifera/ 
curcumin loaded MPEG-PCL nanoparticles possess significantly higher neuroprotective effect in U251 human 
glioma cells compared to the free drugs and their PCL counterparts.  
The in vivo localization of nanoparticles in Zebrafish model suggested that the MPEG-PCL nanoencapsulation had 
efficient and quicker delivery into the larvae compared with the free drug or PCL nanoparticles. Fluorescence 
imaging of nanoparticles revealed that the nanoparticles were distributed throughout the animal. However, in 
terms of fluorescence, the head region of animals treated with MPEG-PCL nanoparticles was more intense than 
that of PCL nanoparticles, indicating that the former might be accumulating in the brain region. Together our 
results suggest that delivery of W. somnifera extract/ curcumin as MPEG-PCL nanoparticles could enhance the 
neuroprotective activity. 
We have also tested the possibility of green synthesis of silver nanoparticles using W. somnifera extract and 
evaluated the biosynthesized silver nanoparticles for their antibacterial activity in a cream formulation. We 
developed a simple, fast and cost effective green synthesis technique for silver nanoparticles with potent 
antimicrobial activity using W. somnifera extract. We also found that catechin, p-couparic acid, luteolin-7-glucoside 
and a non-identified withanolide are the various compounds present in W. somnifera aqueous leaf extract 
responsible for green synthesis. The cream incorporated with silver nanoparticles showed antimicrobial activity 
against a wide variety of clinical isolates. 
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Sumario  
As doenças neurodegenerativas representam 6,3% do gasto geral na saúde e este número tem vindo a aumentar 
continuamente, anualmente, devido ao envelhecimento da população. Apesar do imenso esforço feito na 
investigação de doenças foro neurológico, as doenças neurodegenerativas, tais como Alzheimer ou Parkinson, 
permanecem uma das maiores causas de incapacidade em humanos. Além disso, as doenças 
neurodegenerativas paresentam patogénese multifactorial, com uma complexa combinação de componentes 
genéticos e factores ambientais. Apesar de existirem alguns métodos usados no tratamente destas patologias, 
elas estão associadas a risco de infecção, custos elevados e biodisponibilidade reduzida devido à presença da 
barreira hematoencefálica (BEE). 
 
O uso de plantas medicinais em patologias do foro neurológico tem sido bastante estudado nos anos recentes, 
em virtude das desvantagens da terapia convencional e indo ao encontro da vontade dos pacientes. De um modo 
geral, os produtos farmacológicos derivados de plantas são considerados alternativas seguras. Desde tempos 
remotos que o uso de extractos de plantas tem sido utilizado no tratamento de patologias do foro neurológico. 
Assim como os dos métodos de extracção dos compostos de plantas têm evoluído significativamente, também o 
conhecimento científico da acção destes compostos a nível neurológico tem aumentado de forma substancial. A 
curcuma e Withania somnifera são utilizadas na medicina tradicional asiática no tratamento de várias patologias e 
recentemente foram evidenciadas as suas actividades antioxidante, antidepressiva e neuroprotectora. 
 
Apesar de algumas formulações, compostos e fitofármacos baseados em plantas terem sido identificados como 
potenciais no tratamento de várias neuropatologias o seu desenvolvimento ainda não está no nível requerido para 
a sua utilização. Uma das razões principais deve-se ao facto deste exibirem baixa biodisponibilidade devido à sua 
baixa absorção, metabolismo e eliminação rápida pelo corpo humano. Comparado com os métodos 
convencionais, a administração de fármacos via nanoparticulas tem provado ser uma alternativa eficaz para o uso 
em neuropatologias. Devido a estas vantagens, os pesquisadores têm vindo a desenvolver sistemas baseados em 
nanopartículas como veículos de extractos e compostos de plantas com actividade neurológica reconhecida, para 
o uso em neuropatologias. A nanoencapsulação de compostos e extractos bioactivos numa matriz polimérica 
apresenta várias vantagens, nomeadamente protecção contra a degradação, aumento da solubilidade e 
biodisponibilidade.  
xvi 
 
Neste trabalho foram seleccionadas duas plantas medicinais importantes, com actividade antioxidante, 
antidepressivo e efeitos neuroprotetores comprovados, designadamente W. somnifera e Curcuma sp., para 
nanoencapsulação e posteriores estudos em células U251 (de glioma) e análise de biodistribuição no modelo do 
peixe zebra. 
 
Metodologias de HPLC foram desenvolvidas para identificar a curcumina (princípio activo de Curcuma sp.) e 
whitanólidos presentes em extractos de Curcuma sp e W. somnifera, respectivamente. Extractos obtidos de 
diferentes partes (folhas, raízes e frutos) de W. somnifera foram testados. Os extractos contendo a máxima 
quantidade de withanólidos e curcumina foram seleccionados para nanoencapsulação. Identificou-se que a 
coluna Purospher RP18 (5m) é a ideal para uma separação eficiente e a quantificação simultânea dos 
withanólidos e para uma eficiente quantificação de curcumina em extractos de Curcuma sp.. A quantificação por 
HPLC de diferentes extratos de W. somnifera revelou que o extrato metanólico obtido a partir de tecidos foliares 
contêm a maior quantidade de withanólidos, por comparação com raízes e frutos. Em comparação com C. 
aromatica, a C. longa possui maior quantidade de curcumina. 
 
Extractos de W. somnifera / curcumina foram incorporados em nanopartículas de policaprolactona (PCL) e 
polietilenoglicol metoxi-policaprolactona (MPEG-PCL) usando o método de deslocamento de solvente. As 
nanopartículas preparadas foram caracterizado pelas suas propriedades físico-químicas, tais como tamanho, 
forma, libertação do fármaco e a eficiência de encapsulação. Após a caracterização físico-química, analisou-se a 
citotoxicidade in vitro e a absorção celular das nanopartículas usando células de glioma U251. Além disso, 
avaliou-se o efeito protector das nanopartículas contendo extracto de W. somnifera ou curcumina contra o insulto 
oxidativo induzida por t-BHP, como uma medida de neuroproteção. A biodisponibilidade destas nanopartículas 
contendo o extracto de de W. somnifera ou curcumina foi avaliada ainda num modelo animal, usando alevins de 
peixe zebra. 
 
A caracterização física das nanopartículas revelou que as nanopartículas de MPEG - PCL foram menores em 
dimensão em comparação com as nanopartículas de PCL, independentemente do encapsulamento ter utilizado 
extracto de W. somnifera ou curcumina. A microscopia de varrimento electrónico de transmissão (TEM) das 
nanopartículas revelou uma forma redonda, em geral , embora a superfície das nanopartículas de PCL parece ser 
áspero e poroso. 
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A eficácia de aprisionamento do extracto de W. somnifera e curcumina foi maior em MPEG-PCL, quando 
comparado com o PCL. Observou-se uma libertação rápida. inicial, seguida de um perfil de libertação lenta e 
prolongada para ambos extractos, W. somnifera e curcumina, independentemente do polímero utilizado para a 
encapsulação. 
 
O tratamento de células U251 (giloma) com nanopartículas de PCL e MPEG-PCL carregadas com extracto de W. 
somnifera ou curcumina evidenciou uma absorção celular eficiente de nanopartículas. No entanto, as 
nanopartículas de MPE-PCL mostraram uma melhor internalização em comparação com as nanopartículas de 
PCL, independentemente da sua carga com extracto de W. somnifera ou curcumina. Ensaios de neuroproteção 
mostraram que nanopartículas contendo extracto de W. somnifera ou curcumina protegem as células dos danos 
oxidativos. Enquanto o efeito neuroprotector do extracto W. somnifera aumentou de uma forma dependente da 
dose, a curcumina foi muito eficaz em concentrações mais baixas. Em conjunto, os nossos resultados mostraram 
que em células de glioma humano U251 as nanopartículas de MPEG-PCL carregadas com extracto de W. 
somnifera ou curcumina possuem, significativamente. um maior efeito neuroprotector em comparação com os 
fármacos livres ou seus homólogos encapsulados em PCL . 
 
A localização in vivo das nanopartículas no modelo de peixe zebra sugeriu que a nanoencapsulação em MPEG-
PCL teve uma biodisponibilidade mais eficiente e rápida quando comparado com o fármaco livre ou em 
nanopartículas de PCL. Imagiologia de fluorescência das nanopartículas revelou que as mesmas encontram-se 
distribuídas por todo o animal. No entanto, a região da cabeça dos animais tratados com nanopartículas de 
MPEG-PCL era mais intensa do que com nanoparticulas de PCL. Os resultados sugerem que a entrega de 
extracto de W. somnifera / curcumina por nanopartículas de MPEG-PCL poderá aumentar a atividade 
neuroprotetora. 
 
Também foi testada a possibilidade de biossíntese de nanopartículas de prata usando o extrato de W. somnifera e 
avaliou-se a sua atividade antibacteriana numa formulação de creme. Foi desenvolvido um método rápido, de 
baixo custo e eficaz para a síntese verde de nanopartículas de prata com potente atividade antimicrobiana 
utilizando o extrato de W. somnifera. Também foi evidenciado que entre os vários compostos presentes no 
extracto de W. somnifera, a catequina, ácido p-couparico, luteolina -7- glicosídeo e um withanolido (não 
xviii 
 
identificada) são os responsáveis pela biossíntese das nanopartículas. O creme incorporando nanopartículas de 
prata mostrou actividade antimicrobiana contra uma ampla variedade de isolados clínicos (bactérias e leveduras). 
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List of abbreviations 
AD  Alzheimer Diseases  
AFM  Atomic Force Microscope 
BBB  Blood-Brain Barrier 
CV               Cell viability 
DCM     Dichloromethane 
DMEM          Dulbecco’s modified Eagle’s medium 
DMSO  Dimethylsulphoxide 
DNA  Desoxyribonucleic acid 
DPPH  1,1-diphenyl-2-picrylhydrazyl 
DSC  Differential Scanning Calorimeter 
EA  Ethyl acetate 
FT-IR  Fourier Transform Infrared Spectroscopy 
GBM       Glioblastoma Multiforme 
HPLC-DAD  High performance liquid chromatography diode array  detection 
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1. General Introduction 
1.1 Medicinal plants 
Plants are being used as medicines throughout the human history. Even wild animals instinctively eat certain 
plants to treat themselves certain illnesses. Plant products are one of the major sources of drugs and drug leads 
(Brusotti et al., 2014) as evidenced by a large number of impressive modern drugs have been derived from 
natural sources particularly from plants (Pan et al., 2013). In fact, many of these drugs were developed based on 
their traditional uses medicines. The practice of herbal medicine is extremely well established and documented in 
Asia (Zhang et al., 2011). 
Plants produce and accumulate different types of compounds. Molecules with an important role in basic life 
functions such as cell division, growth, respiration, storage and reproduction were described as primary 
metabolites (Bougard et al., 2001). On the other hand, several other compounds which are not essential for the 
above functions are known as secondary metabolites. For a long time secondary metabolites have been 
considered as waste by-products of plant metabolism. Recent improvement of biochemical techniques and the 
rise of molecular biology have shown that these molecules play a major role in the adaptation of plants to their 
environment including biotic and abiotic challenges. They also act on animals (anti-feeding properties), pathogens 
(phytoalexins) and other plants (allelopathy) (Bougard et al., 2001). Plant secondary metabolites include a vast 
array of compounds that to date sum up to more than 200,000 defined structures. 
Today, the trend in healthcare is moving towards disease prevention rather than treatment, wherein people 
choose herbal medicines, functional foods and nutraceuticals over pharmaceuticals for their wellbeing (Brower et 
al., 2005). There is a shift in universal trend from synthetic to herbal medicine, which can be said “Return to 
Nature”. Medicinal plants have been known for millennia and are highly esteemed all over the world as a rich 
source of therapeutic agents for the prevention of diseases and ailments. In general, people believe that medicinal 
plants are more natural and more easily accessible than manufactured drugs (Petrovska et al., 2012). This drift 
has brought more market opportunities for herbal products, as evidenced by the widespread usage of natural 
products among the therapeutics used in medical treatment. Spurred by the increasing aging population and 
consumer awareness about general health and wellbeing, the global herbal supplements and remedies market 
(GHSRM) exhibited significant growth over the last decade, evidenced by the rapid expansion of plant-based 
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pharmaceutical industries and the increasing demand for medicinal plants. The market research report on herbal 
supplements and remedies accounts Europe as the largest regional market of the entire world, which is followed 
by Asia-Pacific and Japan. 
Studies on medicinal plants are rapidly increasing in order to search for new active molecules or to improve their 
production for the herbal pharmaceutical industries (Poutaraud and Girardin, 2005). A large number of plants 
have been found to contain ingredients that possess antibacterial, antifungal, and anticancer activities, while 
others are recognized for their antioxidant properties. Many bioactive compounds present in plant extracts are too 
complex to be chemically synthesized. Of the 175 small molecules developed from approximately the 1940s to 
date, 131 (74.8%) are non-synthetic. Among these, 85 (48.6%) are either genuine natural products or derived 
directly from natural products (Newman and Cragg, 2012). In some therapeutic areas, the contribution of natural 
products is even greater, e.g. about 78% of antibacterial and 74% of anticancer drug candidates are natural 
products or structural analogues of natural products. In 2000, approximately 60% of all drugs in clinical trials for 
the multiplicity of cancers were of natural origin. Recently some products of higher plant origin have been shown 
to be effective sources of chemotherapeutic agents without undesirable side effects.  More than two thirds of 
anticancer drugs approved between the 1940s and 2006 are natural products or were developed on the basis of 
natural products. Well known examples include Vinca alkaloids (vincristine, vinblastine, vindesine, vinorelbine), 
taxanes (paclitaxel, docetaxel), epipodophyllotoxines (etoposide, teniposide), camptothecine and its derivatives 
(topothecan, irinothecan), and anthracyclines (doxorubicin, daunorubicin,epirubicine, idarubicin).  
1.2. Withania somnifera  
Withania somnifera (WS), commonly known as Ashwagandha, is an important plant in Indian medicine. This 
species is distributed in the dry parts of India, Baluchistan, Pakistan, Afghanistan, Sri Lanka, Congo, South Africa, 
Egypt, Morocco, and Jordan (Kulkarni and Dhir, 2008). It is a green shrub and belongs to Solanaceae family. It 
has several vernacular names including Indian ginseng and winter cherry (Andallu and Radhika, 2000)., In India,  
W. somnifera  is cultivated and either its whole plant extract or separate constituents have been used in ayurvedic 
and indigenous medicine for over 3000 years. Although only the root (known as Asgand) of this plant was 
originally used in Unani medicine, the medicinal potential of its leaves and fruits were also identified sooner and 
adapted in Indian traditional medicine. Currently, different forms (decoction, infusions, ointment powder and 
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syrup) of different parts (leafs, roots, fruits) of this plant are used as medicine all over the world (Gregory et al., 
2014a; Gregory et al., 2014b). W. somnifera is commonly available as a fine sieved powder that can be 
consumed by mixing in water, ghee (clarified butter) or honey. 
The major pharmacological activities of W. somnifera is due to its adaptogenic, anticonvulsant, antisedative, 
anticarcinogenic, immunomodulatory and antioxidative properties (Mishra et al., 2000; Ven Murthy et al., 2010;) 
Steroidal lactones called withanolides are the major active compounds present in W. somnifera  (Dhar et al., 
2006; Misra et al., 2008). More than 40 withanolides (a group of C28 steroids characterized by a 6-membered 
lactone ring in the 9-carbon atom side chain), 12 alkaloids, and several sitoindosides have been isolated from 
different parts (leaves, roots and cherries) of W. somnifera. The medicinal uses of different parts of W. somnifera 
are summarized in the following table.  
Table 1. Medicinal uses of different parts of W. somnifera 
W. somnifera 
Plant parts 
Medicinal uses Reference 
Leaf 
 
W. somnifera  extract act as a free radical scavenger, protecting cells against toxic 
insult 
(Kumar et al., 2014) 
Water extract of  W. somnifera extract poses anti-cancer activity in in-vitro and in-
vivo models 
(Wadhwa et al., 2013) 
Anti-oxidant and anti-bacterial activity (Alam et al., 2012) 
W. somnifera showing great antimicrobial potential against test microorganisms (Singh and Kumar, 2011) 
Anti-proliferative and anti-oxidative activities of  W. somnifera leaf extract from in 
vivo and in vitro 
(Kaur et al., 2004) 
Phenolic acids and flavonoids are responsible for anti-inflammatory activity   (S. Sivamania, 2014). 
Amnesia and its recovery by alcoholic extract of  W. somnifera (Gautam et al., 2013) 
Potential for prevention of neurodegeneration associated with glutamate-induced 
excitotoxicty 
(Kataria et al., 2012) 
W. somnifera leaf extract serve as potential preventive and therapeutic agents for 
neurodegenerative disorders 
(Konar et al., 2011) 
W. somnifera leaf extract protects cells from MAA-induced toxicity by suppressing 
the ROS levels, DNA and mitochondrial damage 
(Priyandoko et al., 2011) 
Anti-diabetic activity of  W. somnifera leaf extract (Gorelick et al., 2015) 
Molecular insight into the immune up-regulatory properties  (Khan et al., 2009) 
Fruits Oxidative and inflammatory (Ojha et al., 2014) 
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Blood–brain barrier permeability of withanolides in W.somnifera fruit extract (Vareed et al., 2014) 
Potent lipid peroxidation inhibitors effect W. somnifera fruits (Jayaprakasam et al., 2004; 
Jayaprakasam et al., 2010) 
Anti-cancer Properties (Oza et al., 2010) 
Diuretic and hypnotic (Saritha and Naidu, 2007) 
Roots 
The root extract of  W. somnifera is rich in several components with strong 
antioxidant properties 
(Bhattacharya et al., 1997; 
Dhuley et al., 1998) 
W. somnifera root extract is used as a dietary supplement (RajaSankar et al., 2009) 
W. somnifera root is used as a Rasayana in the Indian ayurvedic tradition (Khan et al., 2015) 
Aqueous extract of  W. somnifera exhibited antioxidant and anti-arthritic activity and 
reduced inflammation 
(Khan et al., 2015) 
Aqueous extract of  W. somnifera exhibited antioxidant and anti-arthritic activity and 
reduced inflammation 
(Khan et al., 2015) 
Root extract reduced the number of mammary carcinomas that developed and 
reduced the rate of cell division in the carcinomas 
(Khazal et al., 2014) 
Root extract significantly reduced the rate of cell division in the mammary tumors (Khazal et al., 2013) 
Spermatogenic activity (Ambiye et al., 2013) 
Anti-inflammatory effect of W. somnifera root (Gupta and Singh, 2014) 
Stress and anxiety (Chandrasekhar et al., 2012) 
Neuroprotective (Prakash et al., 2013) 
Root extract of  W. somnifera protected the adverse effects of LN intoxication in 
mice 
(Sharma et al., 2012) 
W. somnifera root extract protect neurodegeneration (Baitharu et al., 2013) 
Scalp hair loss (Kalani et al., 2012) 
Aqueous extract of W. somnifera roots has an ability to inhibit the formation of 
mature amyloid- fibrils in vitro 
(Kumar et al., 2012) 
Antiinflammatory and muco-restorative activity (Pawar et al., 2011). 
Enhancing the antioxidant system and protecting the cellular integrity of kidney and 
liver tissues 
(Jeyanthi and Subramanian, 
2010). 
Immunologic effects (Mikolai et al., 2009). 
Anxiety and depression (Gupta and Rana, 2007) 
Anti-cataleptic effect (Nair et al., 2008) 
W. somnifera  root extract have the anti-oxidant and anti-arthritic activity (Khan et al., 2015) 
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1.3. Curcuma sps. 
Curcuma is a genus of about 100 species in the family Zingiberaceae. Rhizomes of the Curcuma longa and 
Curcuma aromatica species is known as turmeric and used in India as traditional medicine as well as cosmetic 
product. Although both species exhibits medicinal values, C. aromatica is mainly used in cosmetic and facial 
products. The bright yellow color present in the turmeric is mainly due to curcumin, a polyphenolic, highly potent, 
nontoxic bioactive compound found in turmeric. Recent research suggests that curcumin may possess a broad 
range of pharmacological activities such as antioxidant, antiinflammatory, antimicrobial, antiviral, antirheumatic, 
and neuroprotective properties. Among the above pharmacological properties, anticancer and antioxidant activities 
of curcumin are well-documented.  Important medicinal uses of C. longa and C. aromatica are summarized below 
(Table 2). 
Table 2. Medicinal uses of C. longa and C. aromatica 
Species Uses Reference 
C. aromatica 
Antibacterial activity (Revathi and Malathy, 2013) 
Antiproliferative and apoptotic (Dai et al., 2013) 
To treat colon carcinoma (Hu et al., 2011) 
Antioxidant activity (Al-Reza et al., 2010) 
Antitussive activity (Marina et al., 2008) 
Chemoprotective effect (Li et al., 2009) 
Hepatoma cell proliferation inhibitory effects   (Wu et al., 2000) 
Antiinflammatory effect of the volatile oil from  
 
(Li, 1985) 
C. longa 
 
 
Wound healing (Pawar et al., 2015) 
Antiinflammatory Activity  (Illuri et al., 2015) 
Antiarthritis (Nonose et al., 2014) 
Inflammatory bowel disease (McCann et al., 2014) 
Antiglycation and antioxidation properties  (Khan et al., 2014) 
Antidiabetic activity  (Ahmad et al., 2014) 
Hepatoprotective  (Sengupta et al., 2011; Kim et al., 
2014) 
Antidepressant (Xia et al., 2007; Yu et al., 2002) 
Antiviral (Kim et al., 2009) 
Antifertility effect (Mishra and Singh, 2009) 
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Neuroprotective (Issuriya et al., 2014) 
Immunostimulatory effect (Yue et al., 2010) 
Antioxidant (Singh et al., 2010) 
Activity against UVB irradiation-induced skin damage (Sumiyoshi and Kimura, 2009) 
Anticonvulsant effect (Orellana-Paucar et al., 2012) 
Antiplatelet property (Lee, 2006) 
Cardioprotective (Mohanty et al., 2004) 
 
 
1.4. Neurological disorders 
Neurological disorders are a major contributors of the global burden of the diseases, which is increasing every 
year due to aging population (Patel et al., 2012). Despite enormous advances in brain research, brain and central 
nervous system disorders remain the world's leading cause of disability. Neurodegenerative diseases such as 
Alzheimer and Parkinson are multifactorial pathogenesis with a complex combination of genetic components and 
environmental factors. Although several treatment methods are available to treat this conditions, they are 
associated with the risk of infection, high cost and limited drug availability (Hu et al., 2009). The lack of efficiency 
in the treatment is mainly due to the presence of blood–brain barrier (BBB) that protects the central nervous 
system from exogenous toxicants, but it also restricts the passage of potential neuro therapeutic compounds. As a 
result the availability of the drug concentration in the brain is insufficient to treat brain disorders. 
In spite of significant efforts to elucidate the causative factors, the pathogenesis of these diseases is still unclear. 
However, excitotoxicity is considered as a common pathologic event underlying neurodegeneration in several 
neurodegenerative diseases, (Kang et al., 2005). Additionally, oxidative stress is also regarded as a factor 
contributing to the development of neurodegenerative diseases  (Behl and Moosmann, 2002). However, whether it 
is a causative factor or a consequence of neuronal death is presently not clear. Together with apoptosis, these 
events seem to underlie the specific neuronal loss affecting areas associated with cognitive functions and 
memory, as in Alzheimer’s disease and other forms of dementia (Pereira et al., 2005; Tannenberg et al., 2006) or 
motor functions and speech, as in Parkinson’s and Huntington’s diseases (Barzilai and Melamed, 2003). 
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1.5. Treatment strategies for neurological disorders 
1.5.1. Herbal medicine for neurological disorders 
The initial drugs used in the treatment of pathologic conditions of the central nervous system (CNS) were based 
on natural resources, especially plants. The scientific understanding of psychoactive plants has advanced 
significantly after the isolation of active constituents, such as morphine from the Opium poppy species (Gomes et 
al., 2009). Hypericum perforatum has been recognized in the treatment of mild to moderate depression and 
many cases; it has been better tolerated than conventional antidepressants (Kasper et al., 2010). Curcumin, the 
natural compound obtained from C. longa has been used as a traditional therapeutic agent in Asian medicine to 
treat various common ailments. Recently it has been reported to possess antioxidant, antidepressant and 
neuroprotective effects (Issuriya et al., 2014;Zaky et al., 2014). The phenolic compounds of Z. piperitum leaf are 
utilized as an effective and safe functional food containing natural antioxidants, reducing the risk of 
neurodegenerative disorders (Jeong et al., 2011). Use of herbal medicine for neurological disorders has gained 
much attention in the recent years, because of the disadvantages of conventional therapies and increased patient 
compliance. In general, drugs obtained from natural sources are considered to be safe alternatives for the 
treatment of several diseases including neurological disorders (Katiyar et al., 2012).   
1.5.2. Drawbacks of herbal medicines in the treatment 
Although a number of herbal medicines have been identified, they are not up to the level for being used in the 
treatment of neurological disorders. This is mainly due to the fact that most of the herbal medicines exhibit poor 
bioavailability due to poor absorption, fast metabolism, and rapid systemic elimination. To overcome these 
problems, several approaches have been employed and among them, modification in the delivery method is a 
promising approach (Tsai et al., 2011).  In particular, herbal medicine based nanocarrier system to treat 
neurological disorder has gained specific interest because of several advantages such as the ability of 
nanoparticles to deliver the drug in a pre-determined rate at a particular site of action, providing high bioavailability 
and low toxicity (Ajazuddin and Saraf, 2010). Compared to the conventional delivery methods, nanoparticle-
mediated drug delivery has been proven to be the ideal way to deliver drugs for neurological disorders. For 
instance, Ray et al. (2011) found that the neuroprotective effect of curcumin was increased when administered as 
polymeric nanoparticle (Ray et al., 2011). Similarly, the efficiency of quercetin to treat Alzheimer´s disease was 
Nanotechnological approaches for neuroprotection and antimicrobial activities                                      G. Marslin 
 
10  
 
 
 
also significantly enhanced when it was delivered to the brain as solid lipid nanoparticles (Dhawan et al., 2011). 
Knowing the advantages and the upcoming trend, pharmaceutical scientists have started designing nanoparticle 
mediated drug delivery systems for herbal medicines with neuro therapeutic potential. 
1.5.3. Transport mechanism of molecules across the blood brain barrier (BBB) 
The treatment for neurological disorders such as schizophrenia, meningitis, migraine, Parkinson’s disease and 
Alzheimer’s disease require the drug to be delivered to the brain at a particular concentration, over a period of 
time (Laquintana et al., 2009). But the transport of the drug molecules to the brain is restricted by the defense 
mechanism of the brain called the blood brain barrier (BBB). Although, this is the life supporting protection of the 
brain, it also eliminates most of the drug from reaching brain, making it an important issue to be considered while 
designing novel drug delivery strategies (Temsamani et al., 2000). 
The mechanism of transcellular diffusion of molecules through the BBB depends on their structural and 
physicochemical properties, such as molecular size, charge, lipophilicity and hydrogen bonding potential. 
Approximately, 98% of small molecule drugs and almost all large molecule drugs (mw>1kDa) do not cross BBB 
(Krishnamoorthy et al., 2014). The transport mechanism of molecules across the BBB is schematically 
represented in Figure 1.  
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Figure 1. Schematic representation showing the transport of drug molecules across the BBB (Adapted from (Gabathuler, 2010)) Small 
lipophilic drugs may enter by penetrating the luminal and abluminal membranes by passive diffusion. Non-diffusible molecules can cross 
the endothelial cells via active carrier-mediated transport. 
Apart from certain compounds that are essential for brain homeostasis, such as amino acids, glucose, 
neuropeptides, and proteins which are transported into the brain via specific endogenous blood-brain transporters, 
only small lipophilic molecules with molecular weight below 400Da are able to cross this complex barrier by 
transcellular diffusion. Even such molecules should not bind to plasma proteins in a high level or form a substrate 
for a transport system at the BBB (Gabathuler, 2010). If the molecular weight of a drug molecule is higher than 
400Da or the drug forms more than eight hydrogen bonds, the probability of crossing the BBB via transcellular 
diffusion, in pharmacologically significant amounts is very low. To allow access for various molecules that are 
essential for brain maintenance and function, specific endogenous blood - brain barrier transporters (carriers or 
receptors) exist in the luminal and basolateral membranes of the endothelium. Carriers are membrane-restricted 
systems commonly involved in the transport of small molecules with a specific size and a molecular weight 
smaller than 600Da. Carrier mediated transcytosis is used in the transport of nutrients to the brain and only drugs 
with specific characteristics that closely mimic the endogenous carrier substrates will be internalized.  
1.5.4. Common strategies of drug delivery to the brain 
Delivery of drugs across the BBB to treat neurological disorders has become a major concern due to the poor 
permeability of therapeutic agents. Hence, various strategies have been introduced to overcome the above-
mentioned problem (Figure 2; Alam et al., 2010).  
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Figure 2. Schematic representation mentioning various approaches through which, the drug can be targeted to the brain.  
1.5.5. Systemic drug delivery  
In systemic drug delivery method BBB is temporarily broken down by injecting a sugar solution like mannitol into 
arteries of the neck. The high sugar concentration in brain capillaries sucks water out of the endothelial cells, 
shrinking them thus opening tight junctions (Hartz et al., 2005) . There are three different techniques employed to 
disrupt tight junctions: (i) osmotic disruption; (ii) MRI –guided focused ultrasound BBB disruption; (iii) Application 
of bradykinin analogue (Etame et al., 2012). But these techniques are used only to temporarily deliver the 
chemotherapeutic agents in patients. Also these techniques allow the drugs to enter even normal cells, causing 
unwanted side effects. Moreover, these methods require hospitalization and anesthesia and also have the 
possibility of causing neuron damage. 
Alternatively, the drug can be delivered to the brain intravenously. However, since this is a non-site specific drug 
delivery that is subjected to rapid clearance from extracellular fluid, a large dose of drug is administered, which is 
the main demerits of this method.  Chemistry based drug delivery is site specific delivery of the drug through 
multistep enzymatic and chemical modification. Mainly the chemical method includes pro drug and drug 
conjugate. The permeability of the drug can be increased by the chemical modifications (Misra et al., 2003). 
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Intra-nasal administration is also applied to deliver the drug in the brain, where, direct movement of the drug from 
sub mucosa space of the nose to the brain and cerebrospinal fluid can be achieved (Pires et al., 2009). Intranasal 
drug administration offers rapid absorption to the systemic blood avoiding first-pass metabolism in the gut wall 
and the liver. Several studies have shown a direct route of transport from the olfactory region to the CNS in animal 
models, without prior absorption to the circulating blood. Since drugs absorbed via the olfactory route do not have 
to cross the BBB it may be possible to deliver substances to the CNS that would otherwise have been blocked 
from entering via the systemic circulation. Through intrathecal injection, the drug can be administered directly into 
cisterna manga of the brain. It is less invasive compared with intra-ventricular administration. This route of 
administration is better for the treatment for spinal diseases. However, there is a chance of drug spreading along 
the distal space of spinal canal  (Miyake and Bleier, 2015). 
 
1.5.6. Biological methods 
The biological method includes the use of monoclonal antibodies, vectors or receptors. Here the main idea is to 
conjugate the drug with antibodies and the conjugate can then be directed towards an antigen residing on or 
within the target tissue, enabling the drug to reach the brain by receptor-mediated transcytosis mechanisms 
(Garcia-Garcia et al., 2005). OX26, 8D3 MAb or R17 217 MAb are antibodies for transferrin receptor (TfR), which 
allowed the conjugated drug to undergo receptor-mediated transcytosis across the BBB of mouse (Pardridge, 
2002). 
1.5.7. Nano based drug delivery systems for the brain 
A promising novel approach to deliver drugs to the targets within the CNS is the employment of colloidal carriers.  
Several reviews have been published and discussed the advantages and disadvantages of nanoparticle- mediated 
drug delivery to the brain (Dinda and Pattnaik, 2013; Wohlfart et al., 2012; Celia et al., 2011). As mentioned 
before the BBB consists of a very tight endothelial barrier, prohibiting the penetration of molecules larger than 
400Da. Therefore, it is less likely that particles will be able to cross the BBB and deliver drugs to the brain. The 
size composition and uptake mechanisms of nanoparticles are certainly different from CNS drugs. Nanoparticles 
are, obviously much larger than the small drug molecules and are only able to enter the brain capillary endothelial 
cells via receptor or adsorptive-mediated endocytosis. Afterwards transcytosis of the nanoparticle to the basal side 
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of the brain endothelial cells is required for them to reach the brain parenchyma (Ragnaill et al., 2011; Zensi et 
al., 2009). 
The success of the colloidal carriers relies on the fact that endogenous biological transport processes are 
generally on the scale of nanometers, and by using them, the nanoparticles have the opportunity to access the 
previously inaccessible disease sites of brain. Furthermore, the immune system is less effective in removing 
particles smaller than several hundred nanometers, allowing a long circulation before clearance. Colloidal carriers, 
because of their small size (in the same size range of several protein–lipid clusters usually transported by cells) 
and large surface area (which functions as a scaffold for plasma proteins and in this way turns nanoparticles in 
biological entities) are a promising method for CNS therapeutics (Ragnaill et al., 2011). 
One of the distinct advantages of particulate carriers is their ability to carry larger amount of drug (higher drug 
load), depending on their structure. Using this approach, the uptake of a single particle into the endothelial cells 
would transport many drug molecules, since particles are more effective in transport than ligand-drug conjugates 
(one or few molecules transported). An additional benefit of the nanoparticles is that no chemical modifications of 
the drug molecule are required for their brain delivery, since nanoparticles can mask the inadequate properties of 
the drug for brain delivery, by incorporating the molecules in their matrix (Wohlfart et al., 2012). The particle size 
and surface characteristics of nanoparticles can be easily modified for controlled and targeted drug delivery. 
Depending on the application and method of preparation, different drug carriers like nanoparticle, nanospheres, 
nanocapsules, drug polymer conjugates, dendrimers and liposomes could be obtained (Figure 3). 
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Figure 3. Different nanocarriers used for drug delivery. Nanocapsules are colloidal carrier systems in which the drug is confined to a 
cavity surrounded by a polymer membrane; whereas in nanospheres the drug is physically and uniformly dispersed. Liposomes are self-
assembled particulate drug carrier systems, which are formed spontaneously by dispersion of phospholipids in aqueous media. 
Nanometre-sized hyperbranched macromolecules consisted of a central core, branching units, and terminal functional groups are called 
dendrimers. 
In order to achieve site-specific action of the drug at therapeutically optimal rate and dose regimen, certain 
aspects should be considered while designing nanoparticles as a delivery system, which include, particle size, 
surface properties and release profile of the pharmacologically active agent (Kreuter et al., 2002). In addition, 
nanoparticle drug delivery systems also have the advantage of stability and long term storage, compared to other 
delivery methods. Moreover, nanosizing leads to increased solubility of components, reduction in the dose via 
improved absorption of active ingredient and higher intercellular uptake. Nanoparticles can penetrate sub-mucosal 
layer because the micro particles are predominantly localized on epithelial lining. Nanoparticle drug delivery can 
be directly administered into systemic circulation without the problem of particle aggregation or blockage of fine 
blood capillaries. However, the brain targeting efficiency of the nanoparticles could be considerably improved by 
several modifications. 
1.5.8. Advancements in the nano drug delivery methods for brain 
Major breakthrough in the field came when these hydrophilic polymers were used to efficiently coat conventional 
nanoparticle surface, to produce an opposing effect on the uptake by the mononuclear phagocytes system (Storm 
et al., 1995). In the past decade, a great deal of work has been devoted to develop PEGlated nanoparticles, which 
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are invisible to macrophages or phagocytes. Such advancement in the nanoparticle system enabled them to 
deliver the chemotherapeutic drug, doxorubicin to treat brain tumors, which until then was shown to have 
limitations in crossing BBB after intravenous administration. 
Delivery of nanoparticles to the brain is based on several factors like polymer choice, surfactant and ligand 
attachment (Xia et al., 2011). Though, the nanoparticle as a drug carrier increased the drug delivery to the brain, 
it has limited capacity to cross BBB. So the surface modification or functionalization of nanoparticles became 
important in order for them to pass the BBB. An example of the surface modified nanoparticle is shown in Figure 
4. 
 
Figure 4. A model picture for Surface modified Nanoparticle. Nanoparticles surface engineered with specific ligands for site specific 
delivery of the drug.  
In fact, the polymer, surface ligands and encapsulated therapeutic agents, all can be modified. This flexibility 
allows control over release kinetics, cell targeting, and treatment strategy, respectively. The kinetic process of 
surface modified nanoparticles and conventional therapies are expressed in Figure 5. 
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Figure 5. Scheme comparing the kinetics of a conventional drug taken orally and the functionalized herbal nanoformulation administered 
intravenously, for brain delivery. The orally taken drug first undergoes gastro intestinal (GI) absorption followed by distribution, 
metabolism and excretion, greatly reducing the dosage of drug. Since the nanoformulation is modified to cross the first pass metabolism 
and functionalized with brain protein specific antibody in its surface to cross the BBB, they reaches the site of action (brain) very soon.   
 
Functionalization of nanoparticles enable them to deliver the drug at a rate directed by the needs of the body, over 
a period of treatment (Mahon et al., 2012). Also, it channels the active entity of drug to the site of action. Thus, 
surface modified/functionalized nanoparticles has significant advantage of achieving the desired pharmacological 
response at a selected site without undesirable interactions with other sites, so that we can expect the drug to 
have a specific action with fewer side effects and better therapeutic index. Conventional dosage forms including 
prolonged-release dosage forms are unable to meet these characteristics. 
1.5.9. Herbal extracts or compounds based nanoformulations 
A number of plant constituents like flavanoids, tannins, terpenoids have shown an enhanced therapeutic effect 
when incorporated into novel drug delivery vehicles at similar or lower dose compared to conventional plant 
extracts. Recently, great attention has been given to the development of herbal nanoformulations (Ansari et al., 
2012). Curcumin is being used for centuries as remedy for many diseases including neoplastic, neurological, 
cardiovascular and pulmonary disorders (Duan et al., 2010). Despite the favorable properties of curcumin, its 
features such as, extremely low solubility in water, poor bioavailability and degradation at alkaline pH, have greatly 
Nanotechnological approaches for neuroprotection and antimicrobial activities                                      G. Marslin 
 
18  
 
 
 
limited its in vivo applications. Curcumin loaded nanoformulations could deliver curcumin into tissue 
macrophages, specifically bone marrow and splenic macrophages in rats and suggested that the intravenous 
delivery system of curcumin using lipid-based nanoparticles may be best for antioxidant and antiinflammatory 
therapies (Sou et al., 2008). The cellular uptake of curcumin could be greatly enhanced by encapsulating 
curcumin into nanoparticles (Liu et al., 2012). 
Cuscuta chinensis is a commonly used traditional Chinese medicine to nourish liver and kidney (Yen et al., 2008). 
Due to the poor water solubility of its major constituents such as flavonoids and lignans, its absorption upon oral 
administration is limited. Oral administration of C. chinensis extract as nanoparticles exhibited 5 times higher 
hepatoprotective and antioxidant effects compared to equivalent concentration of C. chinensis ethanolic extract. In 
addition, the results demonstrated that hepatoprotective and antioxidant effects of 50 mg/kg C. chinensis 
nanoformulation are more effective than the ethanolic extract at a dose of 125 mg/kg. Consequently, it has been 
suggested that absorbency and solubility of poorly soluble herbal medicines could be improved by employing 
nanoparticles (Yen et al., 2008). Similarly, nanoformulation was also developed for quercetin, a well-known 
flavonoid compound found in some plants, foods, and beverages, and has antioxidant, anti-inflammatory, 
anticancer, and antiviral properties. Quercetin is poorly soluble in water, which has limited its absorption following 
oral administration. After fabricating as nanocrystals, the dissolution rate and antioxidant activity were enhanced. 
In fact, the reducing power of the quercetin nanocrystals were more effective than the original quercetin (Sahoo et 
al., 2011). 
Chemotherapeutic drugs such as paclitaxel, a major anticancer drug isolated from the bark of Taxus brevifolia, 
which exhibits activity against malignant glioma and brain metastases have been explored for the treatment of 
brain diseases using nanoparticles. When compared to the commercially available formulation, Taxol with 
Paclitaxel loaded nanoparticles (methoxy poly(ethylene glycol)– poly(-caprolactone) nanoparticles), demonstrated 
increased brain uptake and therapeutic index (Ajazuddin and Saraf, 2010). We summarizes the list of herbal 
nanoformulations, their biological activity, and the rationale for their nanoencapsulation in Table 3. 
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Table 3. Herbal extract and isolated compounds based nanoformulations 
Active 
compound(s)/ 
Plant species 
Biological activity Formulation Aim for Nanoencapsulation Reference 
Curcuminoids 
Anticancer, 
Antioxidant, Neuro 
protection 
SLN, NE, LP 
To enhance bioavailability, cellular 
uptake, prolonged release & targeted 
drug delivery 
(Lim et al., 2011; Anand 
et al., 2010) 
Triptolide Antiinflammatory 
NP 
SLN 
To enhance drug penetration into skin 
& to decrease toxicity 
(Mei et al., 2003) 
Flavonoids 
Hepato protective, 
Antioxidant 
NP 
To protect orally delivered flavonoids 
from GI degradation 
(Leonarduzzi et al., 2010) 
Artemisinin Anticancer NP To achieve sustained release (Chen et al., 2009) 
Beriberine Anticancer NP To achieve sustained release (Khemani et al., 2012) 
Camptothecin Anticancer NP For site specific delivery (McCarron et al., 2008) 
Sylibin 
Anti ulcersctive colitis 
Hepatoprotective, 
Anticancer 
SLN 
Ulcer active Colitis, To obtain Anti-
diabetic activity & to treat oral 
carcinoma 
(Varshosaz et al., 2015; 
Das et al., 2014; 
Gohulkumar et al., 2014) 
Paclitaxel Anticancer NP To improve therapeutic index (Danhier et al., 2009) 
Docetaxel Anticancer NP 
To improve bioavailability& cellular 
uptake 
(Musumeci et al., 2006) 
Resveratrol 
Antioxidant, 
Anticancer 
SLN To enhance bioavailability (Teskac and Kristl, 2010) 
Cuscuta 
chinensis 
Hepatoprotective NP To increased water solubility (Yen et al., 2008) 
Cassia 
auriculata 
Antidiabetic Gold-NP To increase activity & stability (Kumar et al., 2011) 
Zingiber 
officinale 
Antioxidant Gold-NP To achieve anti-bacterial activity (Velmurugan et al., 2014) 
Quercetin 
Antioxidant 
Antiinflammatory 
SLN 
 
To improve brain delivery & to 
enhance dissolution rate 
(Dhawan et al., 2011) 
NP-Nanoparticles, SLN- Solid lipid nanoparticles, NE- Nano emulsion, LP-Liposomes 
 
1.5.10. Herbal nanoformulations for delivery to the brain 
The potential therapeutic effect of herbal medicine is becoming more popular in brain drug delivery (Kennedy and 
Wightman, 2011). Though herbal medicines are safe and are less toxic, to achieve better effect in the brain some 
modification is needed in the delivery methods. A limited numbers of work have been published on herbal 
nanoformulation for the brain delivery, which are summarized in Table 4. 
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Table 4. Nano herbal formulation specific for brain delivery 
Plant/ Active 
compound 
Biological activity Reasons for Nanoencapsulation References 
Ginkgo biloba Neuroprotection  
Brain activation 
To improve the cerebral blood flow & metabolism (Han et al., 2012) 
Quercetin Antioxidant  To improve brain delivery, Increase anti-oxidant 
activity  
(Kumari et al., 2011) 
Hypericum 
species 
Antioxidant  
Neuroprotection 
Protect against oxidative damage (Prakash et al., 2010; Zeisser-
Labouebe et al., 2006) 
Piperine Antiinflammatory  
Antioxidant 
Antidepressant 
To decrease toxicity & to 
increase water solubility 
(Chonpathompikunlert et al., 
2011) 
Curcumin Neuroprotection 
Antioxidant  
To increase the retention time and bioavailability (Kundu et al., 2012) 
 
On of the most important compounds exploited for potent antioxidant and anti-inflammatory activities is curcumin. 
Curcumin could chelate the redox active metals iron and copper (Baum and Ng, 2004).  It is considered extremely 
safe even at very high doses. However, it has restrictive pharmaceutical role because of its very low aqueous 
solubility, rapid systemic elimination, inadequate tissue absorption, poor absorption from the gut and degradation 
at alkaline pH, which severely curtails its bioavailability (Anand et al., 2007;Wahlstrom and Blennow, 1978). For 
instance, curcumin dose of 0.1 g/kg via intraperitoneal route showed that only a trace amount (0.4 g/g) in brain 
tissue (Pan et al., 1999). However, when administered as curcumin loaded PLGA nanoparticles, it exhibited the 
capability to cross BBB and significantly prolong the retention time of curcumin in the cerebral cortex (increased 
by 96%) and hippocampus by 83% (Tsai et al., 2011). In another study curcumin-loaded lipid-core nanocapsules 
were developed to achieve improved antiglioma activity. In C6 and U251MG gliomas, these curcumin-loaded lipid-
core nanocapsules promoted a biphasic delivery of curcumin with enhanced cytotoxicity compared to free (non-
encapsulated) curcumin in mice. In rats bearing C6 gliomas, curcumin-loaded lipid-core nanocapsules (1.5 
mg/kg/day, i.p.) decreased the tumor size, malignance and prolonged animal survival, compared to the same 
dose of non-encapsulated free curcumin. In addition, curcumin-loaded lipid-core nanocapsules administration did 
not alter serum markers and histological parameters of tissue toxicity. Collectively, the data suggested that the 
nanoencapsulation of curcumin in lipid-core nanocapsules is a promising strategy to improve its pharmacological 
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efficacy in the treatment of gliomas (Zanotto-Filho et al., 2013). Curcumin nanoparticles have also been used to 
treat Alzheimer’s disease (AD). Curcumin-conjugated nanoliposomes, with curcumin exposed at the surface, were 
designed to treat AD. They appeared to be monodispersed, stable and non-toxic in vitro. They down regulated the 
secretion of amyloid peptide and partially prevented A-induced toxicity. They strongly labeled A deposits in post-
mortem brain tissue of AD patients and APPxPS1 mice. Injection in the hippocampus and in the neocortex of 
these mice showed that curcumin conjugated nanoliposomes was able to specifically stain the A deposits in vivo. 
Curcumin-conjugated nanoliposomes could find application in the diagnosis and targeted drug delivery in AD 
(Lazar et al., 2013). Other herbal medicines have also been developed as nanoformulations. Extract of H. 
perforatum was encapsulated into gold nanoparticles (Nanohypericum-HPGNPs) and used for its protective role 
against restraint stress-induced behavioral and biochemical alterations in mice. The study report proved that 
Nanohypericum-HPGNPs had good neuroprotective activity compared to H. perforatum extract (Prakash et al., 
2010). Quercetin is another natural flavonoid compound, which is reported to possess anticancer, antifree radical, 
antianaemic, antiinflammatory, and antiallergic properties. Nanoencapsulation of quercetin improved its 
bioavailability and absorption (Pool et al., 2012).  
1.6 Nanotechnological approaches for anti-microbial activities 
In addition to its application in various fields of science and industry, nanotechnology is becoming more popular in 
the area of microbiology in recent years. The natural antibacterial metals, such as silver, zinc, copper and gold 
possess showed better antibacterial activity, when converted as a nano sized materials. The small size and high 
surface to volume ratio enables the metallic nanoparticles to intimately interact with the microbial membrane. In 
general the metal nanoparticles like silver and gold are synthesized by variety of chemical and physical methods, 
which required organic solvents and toxic chemical. The development of plant based green approaches for 
preparing silver nanoparticles is evolving as an important branch of nanotechnology in recent years. Preparing 
nano size particles using plant based natural sources without the use of any harmful chemicals or solvents is 
called green synthesis. Green synthesized silver nanoparticles have shown greater anti-bacterial (Marslin et al., 
2015) and antifungal (Kathiravan et al.,2015) activities. 
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1.7 Objectives 
In the present endeavor, we focused on two important aspects of nanotechnology application regarding plants 
such as, encapsulation of plant bioactive compound or crude extract in polymeric nanoparticles to enhance their 
neuroprotective activity and to green synthesize silver nanoparticles using plant extract to promote antimicrobial 
activity. The present work was undertaken with the following specific objectives: 
1. To develop a simple, fast and reproducible HPLC-RP method for the identification of withanolides from W. 
somnifera and curcumin from Curcuma species. 
2. To prepare and characterize PCL and MPEG-PCL nanoparticles loaded with W. somnifera extract and 
curumin 
3. To study the cellular uptake of W. somnifera extract and curumin loaded PCL and MPEG-PCL 
nanoparticles in vitro  
4. To evaluate the protective effect of W. somnifera extract and curumin loaded PCL and MPEG-PCL 
nanoparticles against tBHP induced oxidative damage in U251 glioma cells 
5. To visualize the biodistribution of W. somnifera extract and curumin loaded PCL and MPEG-PCL 
nanoparticles in an in vivo model  
6. To green synthesize silver nanoparticles using W. somnifera extract, their characterization and evaluation 
of antibacterial activity in cream formulation. 
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2. Preparation and characterization of extracts from Withania somnifera and Curcuma sps 
2.1 Abstract 
W. somnifera, C. longa and C. aromatica methanolic extracts were prepared and characterized by high 
performance liquid chromatography (HPLC) analysis. Different W. somnifera plant parts (leaf, root, fruits) and 
rhizomes (turmeric) of Curcuma species were tested. There is no method available for the quantification of all 
known withanolides (withanolide-A, withanolide-B, withanone, withaferin-A, and 12-deoxy-withastramonolide) 
simultaneously. By studying the influence of column matrix, eluent composition and mobile phase in the 
resolution of compounds, we have developed a reverse phase HPLC (RP-HPLC) method. Among the different 
columns tested, Purospher C-18 and Lichrospher C-18 exhibited the best resolution of W. somnifera compounds. 
On the other hand, Purospher C-18 column was used to analyze extracts of C. longa and C. aromatica rhizomes 
to quantify curcumin. 
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2.1. Introduction 
W. somnifera is referred as Indian ginseng due to its high medicinal value and nontoxic property. Various parts of 
this plant have been used to treat various neurological disorders, geriatric debilities, arthritis, stress and 
behaviour-related problems (Dhuley, 2001;Pratte et al., 2014). Currently, different part (leafs, roots, fruits) of this 
plant are used all over the world as decoction, infusions, ointment powder and syrup. Moreover, raw plant 
material and extracts of this species are sold as dietary supplements in the USA for increasing energy and 
endurance, strengthening immune function, and helping the body overcome imbalance (Alam et al., 2011). 
Although a few HPLC and TLC methods are available for the quantification of withaferin A (Chib et al., 2013; 
Ganzera et al., 2003; Khajuria et al., 2004; Murthy et al., 2008; Mundkinajeddu et al., 2014), there is no 
adequate method for the separation and quantification of all known withanolides (withanolide-A, withanolide-B, 
withanone, withaferin-A, 12-deoxy-withastramonolide) simultaneously. In fact, most of these methods are 
disadvantages, as the acetylation of withaferin-A is required prior to analysis and the separation time is too long. 
Similarly, Curcuma species are used for medicinal and cosmetic purposes since ancient time in India (Aggarwal et 
al., 2013; Gupta et al., 2013). Many pharmacological studies have revealed that the poly phenolic compound 
curcumin as the active compound of Curcuma species. For example, curcumin exhibits anti-oxidant (Ak and 
Gulcin, 2008), anti- cancer (Aggarwal et al., 2003), anti-inflammatory (Menon and Sudheer, 2007), anti-microbial 
(De et al., 2009) and extensive neuroprotective properties (Kuo et al., 2011; Ray et al., 2011). Although several 
analytical methods have been developed for the identification and quantification of curcumin, only limited studies 
are available for the quantification of curcumin from different Curcuma species. Hence, the main focus of the 
study is (i) to develop HPLC analytical method, which includes simultaneous identification and quantification of 
major withanolides in W. somnifera extracts and (ii) to compare curcumin contents of different Curcuma species. 
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2.2. Materials and methods 
2.2.1. Chemical and reagents 
Withanolides (withanolide-A, withanolide-B, withanone, withaferin-A, 12-deoxy-withastramonolide) standards were 
obtained as gift from Natural Remedies (Bangalore India). Curcumin standard was purchased from Sigma Aldrich 
(Germany). All the solvents used in this study were of HPLC analytical grade purchased from Merck (Germany). 
2.2.2. Plant materials 
W. somnifera leaf, fruit and root were collected from Bangalore, India. Rhizomes of C. longa and C. aromatica 
were collected from Tamilnadu, India. The collected materials were dried under shade, finely powdered and stored 
in an airtight container. 
2.2.3. Preparation of extract 
Powdered leaves, roots and fruits (W. somnifera) and rhizomes (C. longa and C. aromatic) were separately 
extracted. Briefly 200 mg sample was taken in a 20 ml glass vial and 10 ml of 90% methanol was added. 
Samples were subjected to sonication for 20 min under dark at ambient temperature. After sonication, 1 ml of 
extract was taken in an eppendorf tube and centrifuged at 5000 rpm for 5 min. Supernatant was filtered through 
a 0.45 µm Nylaflo membrane filter (Pall Corporation, USA) and submitted to HPLC–DAD analysis. 
2.2.4. Preparation of standards 
Stock solutions (500 µg/ml) of withanolides (withanolide-A, withanolide-B, withanone, withaferin-A, and 12-deoxy-
withastramonolide) were prepared by dissolving these compounds in methanol and DMSO (1:1) mixture. 
Curcumin stock (500 µg/ml) was prepared in methanol. All the stocks were prepared in 4 ml glass vials and 
stored at 4 °C.  For HPLC working standard, 100 µl of each withanolide stock solution (withanolide-A, withanolide-
B, withanone, withaferin-A, and 12-deoxy-withastramonolide) was taken into a HPLC vial and the volume was 
made up to 1 ml using methanol to obtain a final concentration of 50 µg/ml of each compounds. Similarly, 
working standard of curcumin (50 µg/ml) was prepared methanol. 
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2.2.5. HPLC analysis 
HPLC analyses were performed in a Merck-Hitachi LaChrom Elite high pressure liquid chromatography apparatus 
(Hitachi, Japan), equipped with an L-2450 DAD detector, L-2300 column oven, L-2130 quaternary pump and L-
2200 auto sampler. EZChrom Elite software program was used for the data acquisition. We have tested the 
separation of compounds in four different columns namely Hypersil BDS 100×4cm 3 µm, Hypersil 120-5 ODS 
5µm, Lichrospher RP-18 5µm and Purospher RP-18 5 µm column (Merck, Germany). Once the column was 
selected, separation of compounds was first tested by two-phase mobile (eluent) system. The tested compositions 
for two phase mobile system were (i) water/ acetic acid (0.1%) and methanol, (ii) water/formic acid (0.1%) and 
methanol, (iii) water/formic acid (0.1%) and acetonitrile and (iv) water/acetic acid (0.1%) and acetonitrile. To 
further improve the separation, we tested three-phase mobile phase (eluent) system which consist of 0.1% acetic 
acid- water as eluent A, 0.1% acetic acid-acetonitrile as eluent B and 0.1% acetic acid- methanol as eluent C. 
Detection was achieved with DAD detector and the data for all peaks were accumulating in the range 200-400 nm 
and the chromatograms were recorded at 235 nm.  
For Curcuma extracts, chromatographic separation was carried out using Lichrospher RP-18 5 µm (Merck, 
Germany) column using water/formic acid (99:1) and methanol as mobile phases. 
2.2.6. Identification and quantification of compounds 
The withanolides were identified with the help UV-spectrum of standard withanolides at 235 nm. Quantification 
was carried out by external standard method comparing the chromatogram, retention time and area of peak of 
standard and extracts. In the same way curcumin was identified with the help UV-spectrum of standard at 425 
nm. 
2.3. Results and discussion 
2.3.1 Influence of columns on the separation of withanolides 
To optimize the column for identification and quantification withanolides, we have tested four types of reverse-
phase-HPLC columns. Among these, Purospher RP-18 5µm column was identified as best column by the better 
separation (Table 1). The other columns (Hypersil BDS 100×4cm 3 µm, Hypersil 120-5 ODS, Lichrospher RP-18 
5 µm) showed a weak separation and most of the time the compounds were superimposed together. The 
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influence of columns on the separation of withanolides from different parts of W. somnifera is shown below 
(Figure 1-3).  
Table 1. Retention time of withanolides in Purospher RP-18 e 5µm column 
 
Eluent Composition 
Compounds 
Retention time 
STD Leaf Root Fruits 
 
 
Formicacid:methanol 
 
 
a 
b 
c 
d 
e 
17.10 
17.63 
17.79 
18.03 
20.12 
Yes 
No 
Yes 
Yes 
No 
  
 
Formicacid:actonitrile 
 
a 
b 
c 
d 
e 
8.91 
11.10 
12.73 
12.94 
17.99 
Yes 
No 
No 
Yes 
No 
  
 
Aceticacid:acetonitrile 
 
a 
b 
c 
d 
e 
8.87 
11.01 
12.66 
12.88 
17.90 
Yes 
No 
No 
Yes 
No 
  
Aceticacid:methanol 
a 
b 
c 
d 
e 
19.08 
19.67 
20.10 
20.48 
22.42 
Yes 
No 
No 
Yes 
No 
  
 
 
Figure 1. HPLC chromatogram recorded at 235 nm of standards (A) and W. somnifera leaf extract (B) showing peaks of withanolides (a- 
withanolide-A. b- withanolide-B, c- withanone, d- withaferin-A, e- 12-deoxy-withastramonolide) separated by Hypersil BDS 100×4cm 3 µm. 
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Figure 2. HPLC chromatogram recorded at 235 nm of standards (A) and W. somnifera leaf methanolic extract (B) showing peaks of 
withanolides (a- withanolide-A. b- withanolide-B, c- withanone, d- withaferin-A, e- 12-deoxy-withastramonolide) separated by Hypersil 120-5 
ODS 5µm column. 
 
Figure 3. HPLC chromatogram recorded at 235 nm of standards (A) and  W. somnifera leaf methanolic extract (B) showing peaks of 
withanolides (a- withanolide-A. b- withanolide-B, c- withanone, d- withaferin-A, e- 12-deoxy-withastramonolide) separated by Purospher RP-
18 5 µm column using water/ acetic acid (0.1%) and methanol as eluent system. 
 
2.3.2. Influence of eluent composition on the separation of withanolides 
Once the optimum column was selected, to further improve the separation of withanolides, we tested different 
two-phase eluent system. Comparatively, a better separation was achieved in water/ acetic acid (01%) and 
methanol eluent system. However, a minor difficulty was noticed in the separation of withanone and withaferin-A 
(Figure 3A). Both of these compounds (peaks c and d) were superimposed in the chromatogram posing problems 
in their identification and quantification. Hence, we went further to test a three-phase eluent system for HPLC 
identification and quantification all the withanolides. The final eluent gradient used for sample analysis is shown in 
(Table 2). The three-phase eluent system avoided the problem related to the separation with withanone and 
withaferin-A observed in the two-phase eluent system. Moreover, it showed a better separation of all the five 
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withanolide standards (Table 3; Figure 4A). However, withanolide-B could not be detected in any of the W. 
somnifera extracts (Table 3; Figure 4). On the other hand, withanolide-B could be efficiently detected in the two-
phase eluent system (Figure 1-3).  
Table 2. Elution gradient selected for the analysis of the methanol extract of W. somnifera 
Time (min) %A %B %C 
0 45 15 40 
5 45 15 40 
20 15 15 70 
25 15 15 70 
30 45 15 40 
40 45 15 40 
 
Table 3. Retention time of withanolides in Purospher RP-18 e 5µm column in three phase eluent system 
Eluent 
Composition 
Compounds 
Retention time 
STD Leaf Root Fruits 
Acetic acid: 
Acetonitrile: 
Methanol 
A 
B 
C 
D 
E 
13.56 
15.10 
16.17 
16.67 
20.92 
Yes 
No 
No 
Yes 
Yes 
Yes 
No 
Yes 
Yes 
Yes 
Yes 
No 
Yes 
No 
No 
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Figure 4. HPLC chromatogram of standards (A), W. somnifera methanolic extract of leaf (B), root (C) and fruit (D) showing peaks of 
withanolides (a- withanolide-A. b- withanolide-B, c- withanone, d- withaferin-A, e- 12-deoxy-withastramonolide) separated by Purospher RP-
18 5 µm column.  
2.3.3. Identification and quantification of withanolides  
Withanolides were identified by retention time and UV spectrum. The chemical structure and UV-Vis spectrum of 
five standard withanolides detected Diode array are shown in Figure 5 A-B. From the chromatograms recorded 
(Figure 4), we could quantify the amount of various withanolides present in different extracts by comparing the 
peak area of standard. However, previously reported HPLC methods were restricted to the identification of 
withanolide -A and withanolide-D (Ganzera et al., 2003; Bala et al., 2004). Although Khajuria and collaborators 
(Khajuria et al 2004) have reported simultaneous determination of four withanolides, withanolide-B could not be 
determined in their study. In our method, all the five standard withanolides including withanolide-B could be 
efficiently determined arguing for the robustness of the developed method.   
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Figure 5A. Chemical structure of withanolides  
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Figure 5B. UV-Vis spectrum of withanolides  
Although the highest content of withanolides was present in leaf extract, we could only detect three withanolides 
namely withanolide-A, withaferin-A, and 12-deoxy-withastramonolide (Table 4). Compared to roots, fruits contained 
more withanolides. The maximum number of 4 withanolides with the exception of withanolide-B could be detected 
in the root extract. 
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Table 4. Withanolides content of different parts of W. somnifera 
Compounds STD (µg/ml) 
(mg/ g wt dry biomass) 
Root Leaf Fruit 
withanolide-A  50 0.098 1.344 0.100 
withanolide-B  50    
withanone  50 0.058   
withaferin-A  50 0.065 0.346 0.002 
12-deoxy-withastramonolide 50 0.150 0.143  
 
2.3.4. Identification and quantification of curcumin 
Curcumin is the major compound responsible for the biological activities of Curcuma sp. Since many HPLC 
methods have been reported for identification and quantification of curcumin (An et al., 2014; Wichitnithad et al., 
2009), we restricted our analysis with the comparative quantification of curcumin. From the literature and the 
results of our thin layer chromatography (TLC) study we found that methanol is the ideal solvent for extracting 
curcumin. Elution gradient of curcumin in selected column for the analysis Lichrospher RP-18 5 µm is described 
in Table 5. Curcumin was identified by retention time and UV-Vis spectrum (Figure 6D). Our quantification result 
revealed that C. longa extract possessed higher amount of curcumin (1.49 mg/g dry wt biomass) than C. 
aromatica (0.55 mg/ g dry wt biomass).  
Table 5. Elution gradient specification of HPLC-DAD analysis of curcumin 
Time (min) %A %B 
0 15 85 
5 30 70 
20 45 55 
25 15 15 
30 50 50 
40 85 15 
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Figure 6.  HPLC chromatograms of methanolic extract obtained from rhizomes of Curcuma species separated with Lichrospher RP-18 5 
µm column. Standard curcumin (A), Methanolic extract of C. longa (B), Methanolic extract of C. aromatica (C). UV-Vis Spectrum of 
curcumin at 425 nm (D). 
 
2.4. Conclusion 
We have found that the methanolic extract obtained from leaf tissues of W. somnifera possessed the highest 
amount of withanolides compared to roots and fruits. Purospher RP-18 e 5 µm column is ideal column for the 
efficient separation and simultaneous quantification of withanolides. C. longa had higher amount of curcumin 
compared to C. aromatica. 
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3. Preparation and characterization of Withania somnifera extract and curcumin loaded polymeric  
 
3.1. Abstract 
W. somnifera extract and curcumin were encapsulated in poly --caprolactone (PCL) and methoxy poly-ethylene 
glycol poly --caprolactone (MPEG-PCL) nanoparticles by solvent displacement method. Prepared nanoparticles 
were characterized for their physico-chemical properties. Laser Doppler anemometry analysis revealed that the 
PCL nanoparticles loaded with W. somnifera extract ranged between 220-250 nm, whereas W. somnifera 
extract loaded MPEG-PCL nanoparticles are 50-80 nm in size. The size of curcumin loaded PCL and MPEG-
PCL nanoparticles ranged between 200-240 nm and 30-70 nm respectively. TEM images revealed that all 
nanoparticles were spherical in shape. Analysis of WSE and curcumin content of nanoparticles synthesized 
using various drug-polymer ratio revealed that 1:10 ratio is the best for encapsulation. The entrapment efficacy 
of WSE was higher in MPEG-PCL (54.4%) compared to PCL (31.2%). Likewise, encapsulation of curcumin was 
higher in MPEG-PCL nanoparticles (85.8%) compared to PCL nanoparticles (72.2%). W. somnifera extract and 
curcumin loaded PCL and MPEG-PCL nanoparticles showed an initial burst release, followed by an extended 
release profile.  
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3.2. Introduction 
Nanotechnology has gained much attention in the recent years due to its wide range of application in physics, 
chemistry, biology and medicine. Particularly, nanoparticles mediated drug carrier system has emerged as a 
powerful methodology due to the unique accumulation behavior of nanoparticles at the targeted site (Dumont 
et al., 2002). Nanoparticles are submicron-size carrier systems composed of natural or synthetic polymers with 
the size range of 10–1000 nm. For nanoparticle mediated drug delivery, the therapeutic agent of interest may 
be dissolved, entrapped or encapsulated within the biodegradable polymer matrix to achieve extended drug 
release over a period of time, as the polymer degrades (Marslin et al., 2009). Moreover, nanoencapsulation 
increases the efficacy of the drug, improves its circulation time and stability while decreases its toxic side 
effects (Sheeba et al., 2014). 
Although, previous pharmacological studies have explored the importance of plant active compounds such as 
curcumin and withanolides, their clinical application is limited due to their poor aqueous solubility which 
decreases their bioavailability and in-vivo pharmacokinetics, compromising the efficacy (Jagetia and Aggarwal, 
2007). Aqueous solubility is an important parameter for the initial phase of drug development. Approximately, 
more than half of the new reactive molecular entities were not successfully developed because of their 
hydrophobicity (Gong et al., 2010). So, it is crucial to develop water-based formulations with controlled release 
property in order to improve the clinical applications of plant bioactive compounds (Li et al., 2005). 
Polymeric nanoparticles encapsulated with plant active compounds have been proven to be successful in 
increasing the bioavailability and retention time of herbal medicines.   For example the neuroprotective effect of 
curcumin has increased after converting it into polymeric nanoformulation (Ray et al., 2011). Likewise, 
Dhawan et al demonstrated that solid lipid nanoparticles of quercetin, deliver the drug to the brain and have 
greater potential to treat Alzheimer´s disease (Dhawan et al., 2011). 
Today, several polymers are in use. Among them, MPEG-PCL is an amphiphilic block copolymer composed of 
hydrophilic and hydrophobic segments. The characteristic structure of amphiphilic copolymers enables them to 
self-assemble into nanoscale core shell spherical structures with the hydrophobic part as the inner core and 
the hydrophilic part as the outer shell (Hu 
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et al., 2003). While it is easy for the hydrophobic core to incorporate lipophilic drugs, enabling their sustained 
release profile, the outer shell formed by the hydrophilic part help the nanoparticles to effectively escape the 
scavenging activity of the reticuloendothelial systems after systemic administration thereby leading to a long 
circulation time (Lu et al., 2013; Aditya et al., 2015; Shao et al., 2011). In this study, we have developed and 
characterized W. somnifera extract and curcumin in poly (-caprolactone) PCL and methoxy poly(ethylene 
glycol) Poly (-caprolactone) MPEG-PCL nanoparticles. 
3.3. Materials and methods 
3.3.1. Plant materials and chemicals 
Authenticated samples of W. somnifera leaf materials were collected from Bangalore, India. After collection, 
leaves were dried under shade, powdered and stored in an airtight container. Standard compounds 
(withanolides withanolide-A, withanolide-B, withanone, withaferin-A, 12-deoxy-withastramonolide) were obtained 
as a gift from natural remedies, Bangalore India.  
Curcumin was purchased from Sigma Aldrich, Germany. Poly(ethylene glycol) methyl ether (MPEG, Mn 2000, 
Fluka, USA), -caprolactone (-CL, Alfa Aesar, USA), stannous octoate (Sn(Oct) 2, Sigma, USA),3-(4,5-dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (methyl thiazolyl tetrazolium, MTT, Sigma, USA), Dulbecco's 
Modified Eagles Medium (DMEM,  HyClone Thermo Scientific, USA) and fetal bovine serum (BioChrom KG, 
Berlin, Germany) were purchased. All the solvents used in this study are HPLC analytical grade and they were 
purchased from Merck (Germany). 
3.3.2. Synthesis and characterization of block copolymer methoxy poly (ethyleneglycol)-poly(-caprolactone) 
MPEG-PCL copolymer was prepared by ring-opening polymerization of -CL and MPEG in the presence of 
stannous octoate as catalyst. Briefly, 5 g of each -Caprolactone and 5 g of MPEG, and 0.1% catalyst were 
added into a 50 ml dried glass reactor (previously flamed and nitrogen purged several times) and sealed under 
reduced pressure (5 mmHg). The reaction was carried out at 140 °C for 24 hrs and then  terminated by 
cooling in water. The reaction product was then dissolved in CHCl3 and precipitated with an excess of 
methanol/ diethyl ether to obtain a white product. The product was dried under vacuum at 40 ° C for 48 hrs. 
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The synthesized copolymer was characterized by Fourier transform infrared spectroscopy (FTIR) by KBr pellet 
method (1 mg of polymer was mixed with 200 mg of KBr in mortar) and measured with Bomem MB104 193 
spectrometer in the range of 4000−500 cm 194 −1.  The 1H nuclear magnetic resonance spectroscopy (1H 
NMR) analysis was performed using chloroform as solvent in a Brucker (Avance III, 400 MHz) spectrometer at 
a temperature of 25 ° C, with 1 second delay and 128 accumulation cycles. 
3.3.3. Preparation of W. somnifera Extract 
As discussed in the previous chapter W. somnifera leaf extract has the higher amount of withanolides. Hence, 
we selected W. somnifera leaves for the extraction of withanolides. Finely powdered W. somnifera leaves (50 g) 
were extracted in aqueous methanol solution (90%) with sonication for 1 hrs in the dark at ambient 
temperature. The liquid phase was filtered through 0.45 µM nylon membrane (Poll Corporation, USA) and 
purified with dichloromethane. HPLC–DAD analysis of W. somnifera extract was performed to confirm the 
presence of bioactive compounds (withanolide-A, withanolide-B, withanone, withaferin-A, 12-deoxy-
withastramonolide) in the extract. 
3.3.4. Preparation of W. somnifera extract and curcumin encapsulated nanoparticles 
Both W. somnifera leaf extract and curcumin encapsulated nanoparticles were prepared by solvent 
displacement method. To prepare W. somnifera extract loaded nanoparticles, 100 mg of PCL or MPEG-PCL 
and 10 mg of W. somnifera extract were dissolved in 5 ml of dichloromethane. Curcumin loaded nanoparticles 
were prepared by dissolving curcumin and the respective polymers in acetone. These organic solutions were 
separately introduced into 50 ml of aqueous solution containing 1% of Pluronic (F-68) under continuous 
magnetic stirring for 4 hrs. The residual organic solvent was removed by placing the sample in rotary 
evaporator at 37 °C. After removal of organic solvent the nanoparticles suspension centrifuged at 20000 rpm 
for 15 min to pellet down the nanoparticles. The pelleted nanoparticles were freeze dried and stored 4 °C for 
further use. For the PCL nanoparticles after the preparation the nanoparticles suspension was centrifuged at 
20000 rpm for 15 min to pellet down the nanoparticles. PCL and MPEG-PCL empty nanoparticles were 
prepared in the absence of W. somnifera extract or curcumin. Self-assembly of PCL and MPEG-PCL 
nanoparticles formation is illustrated in Figure 1. In order to obtain nanoparticles with optimal characteristics 
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different empty nanoformulations and nanoparticles encapsulated with W. somnifera extract /curcumin were 
prepared by altering the concentrations of polymer, and stabilizer (Table 1).  
 
 
Figure 1. Schematic representation of W. somnifera extract (WSE) and curcumin loaded nanoparticles preparation by solvent 
displacement method. Preparation of PCL nanoparticles (A), Preparation of MPEG-PCL nanoparticles (B).  
 
Table 1. Various compositions of polymer, drug and stabilizer used in the preparation of nanoparticles 
Formulation code Drug (mg) Polymer (mg) Organic solvent (ml) Stabilizer (%) 
PCL1 10 50 5 0.5 
PCL2 10 100 5 0.5 
PCL3 10 50 5 1 
PCL4 10 100 5 1 
PCL5 10 100 5 1.5 
MPCL1 10 50 5 0.5 
MPCL2 10 100 5 0.5 
MPCL3 10 50 5 1 
 63 
 
 
For in-vitro cellular uptake and in-vivo localization studies (Chapter 4), coumarin-6 co-encapsulated with W. 
somnifera extract nanoparticles were prepared following the same methods mentioned above. In brief, 100 mg 
of PCL or MPEG-PCL and 2 mg coumarin-6 and 8 mg W. somnifera extract were dissolved in 5 ml of 
dichloromethane. These organic solutions were separately introduced into 50 ml of aqueous solution 
containing 1% of Pluronic (F-68) under continuous magnetic stirring for 4 hrs and the nanoparticles were 
isolated as per the aforementioned method.  
 
3.3.5. Physicochemical characterization of W. somnifera extract and curcumin loaded nanoparticles 
3.3.5.1. Particle size, polydispersity index and Zeta potential 
Particle size distribution, polydispersity index and Zeta potential of the W. somnifera extract and curcumin 
loaded PCL, and MPEG-PCL nanoparticles were determined in a Zetasizer (Zetasizer nano ZS, Malvern 
Instruments, UK). For the measurements, 500 µL of nanoparticle suspension was diluted with 500 µL of 
ultrapure water and used for the analysis. The zeta potential was determined based on the electrophoretic 
mobility of nanoparticles in an aqueous solution using laser Doppler velocimetry and phase analysis light 
scattering. 
3.3.5.2. Nanoparticle morphology 
Morphological characteristics of the nanoparticles were confirmed by transmission electron microscopy (TEM, 
JEOL-1400, 902A Jeol Ltd) after negative staining with sodium phosphotungstate solution (2%, w/w). Freshly 
prepared W. somnifera extract or curcumin encapsulated nanoparticle suspension was diluted with 500 µL of 
ultrapure water, dropped onto copper grid (400 mesh) and used for analysis. 
3.3.5.3. X-ray diffraction (XRD) analysis 
XRD studies were performed using an X-ray diffractometer (Philips, PW1710) with a horizontal goniometer. The 
samples were placed in the sample holder and scanned at a rate of 1° min -1 from 0° to 60°.  
MPCL4 10 100 5 1 
MPCL5 10 100 5 1.5 
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3.3.5.4. Differential scanning calorimetry 
The physical state of W. somnifera extract and curcumin entrapped in the nanoparticles was characterized by 
differential scanning calorimetry (Universal V4.7A TA Instruments). The endothermic melting temperature of 
the drug (W. somnifera extract and curcumin), polymer (PCL and MPEG-PCL) and W. somnifera extract or 
curcumin loaded PCL and MPEG-PCL nanoparticles was measured by placing 5-10 mg samples on aluminum 
pans with lids and scanning between 25 °C and 320 °C at the rate of 5 °C per min, under nitrogen 
atmosphere. 
3.3.5.5. Encapsulation efficiency 
Concentration of withanolides encapsulated in the nanoparticles was estimated. Briefly, 20 mg of W. somnifera 
extract loaded nanoparticles was dissolved in 2 ml of methanol subjected to sonication for 5 min to disrupt the 
nanoparticle structure. Then the sample was centrifuged at 10000 rpm for 10 min to get a clear supernatant 
for analysis. HPLC analyses were performed in a Merck-Hitachi LaChrom Elite high pressure liquid 
chromatography equipped an L-2450 DAD detector, L-2300 column oven, L-2130 quaternary pump and L-
2200 auto sampler. Chromatographic separations were carried out at 30 ºC, on a Purospher RP-18e column 
(Merck, Germany), using 0.1% acetic acid in water (solvent A),  0.1% acetic acid in acetonitrile (solvent B) and 
0.1% acetic acid methanol as the mobile phases.  W. somnifera extract was filtered (Nylaflo membrane 0.45 
µM) prior to HPLC analysis. 
As mentioned above, encapsulation efficiency of curcumin nanoparticles was also determined, but using RP-
HPLC. Chromatographic separation was carried out on an RP C18 Lichrospher column (Merck, Germany), 
using water/formic acid (99:2) and methanol as the mobile phases and absorbance were recorded at 425 nm. 
The encapsulation efficiency of formulations was determined by the equation: 
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3.3.5.6. In- vitro release profile 
In- vitro release studies were carried out using pH 7.4 phosphate buffer saline (PBS) by dialysis bag method 
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with a molecular weight cut-off of 12,000- 14,000 Da. Twelve hours prior to usage, the semi-permeable 
membrane was kept in PBS solution. Briefly, 20 mg of W. somnifera extract loaded nanoparticles were placed 
in the dialysis bag. The dialysis tubes were incubated in 50 mL of pre-warmed PBS (37 °C, pH 7.4). One 
milliliter of the sample was withdrawn from the incubation medium and release of withanolides was quantified 
by HPLC as described above. After sampling, equal volume of fresh PBS was immediately added into the 
incubation medium. 
Similarly, dialysis bag method was followed for in-vitro release studies of curcumin nanoparticles, although with 
small modifications. Briefly, 20 mg of curcumin nanoparticles were placed in dialysis tubes. The dialysis tubes 
were incubated in 50 mL of pre-warmed PBS (37 °C, pH 7.4) containing Tween80 (1% v/v). One milliliter of 
the sample was withdrawn from the incubation medium and release of curcumin was quantified by HPLC as 
described above. After sampling, equal volume of fresh PBS was immediately added into the incubation 
medium. The concentration of withanolides or curcumin released from the nanoparticles was expressed as a 
percentage of the total curcumin in the nanoparticles and plotted as a function of time. 
3.3.6 Statistical analysis 
All data were analyzed statistically and graphs were generated using GraphPad 5 software (Prism, USA). Data 
are expressed as the mean ± S.E.M., of the indicated number of experiments. The significance of the 
differences between the mean values was evaluated using the unpaired two-tailed Student’s t-test. A difference 
at p≤0.05 confidence level was considered significant 
3.4. Results and discussion 
In the recent years, herbal medicine has gained much attention because of the therapeutic efficacy and less 
toxicity at even higher doses (Ribeiro et al., 2013). To enhance the therapeutic activity of herbal medicine, 
different strategies have been attempted. Among them, nanoparticles mediated drug carrier systems have 
shown a higher percentage of successes (Bharali et al., 2011). Recently, a variety of novel carriers for herbal 
medicines such as liposomes, nanoparticles, nanocapsules, phytosomes, nanoemulsion and microspheres 
have been reported with significant success rate (Ajazuddin et al., 2014). Incorporation of the herbal extracts 
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into these novel formulation systems have the greatest  advantage to overcome the major problems, such as 
their bulk dosing and less absorption, enticing the attention of major pharmaceutical corporations. 
In addition, drugs encapsulated into a polymer matrix also provide other valuable aspects including protection 
from degradation, enhanced drug solubility, targeting ability of the drug to the specific site and less toxicity 
(Aditya et al., 2015). In this work we have encapsulated W. somnifera extract and curcumin successfully in 
PCL or MPEG-PCL polymer by solvent evaporation method.  
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3.4.1. Characterization of block co-polymer 
 
Figure 2. The 1H NMR spectrum of the MPEG-PCL copolymer (A), MPEG (B), PCL (C). 
 
MPEG-PCL block copolymers were synthesized by ring opening polymerization of -CL in the presence of MPEG 
with catalyst stannous octoate. The copolymers were characterized by 1H NMR. The 1H NMR spectrum of the 
MPEG-PCL is shown in (Figure 2A).  The peaks at 1.30-1.33, 1.57-1.62, 2.3-2.28 and 3.33 ppm were 
assigned to the methylene protons in the PCL unit. The peaks at 3.5 ppm were attributed to the methylene 
protons of the PEG units. Presences of these peaks have confirmed the formation of MPEG-PCL copolymer. 
  
68 
 
 
The FT-IR spectrum for a typical MPEG-PCL copolymer is shown in (Figure 3). The MPEG-PCL copolymer 
clearly exhibited peaks characteristic of both MPEG and PCL. The absorption band at 1727 cm-1 was attributed 
to C=O stretching vibration of -CL. The absorption band at 2890 cm-1 and 2946 cm-1 were attributed to C-H 
stretching vibration of MPEG-PCL and -CL, confirming the formation MPEG-PCL.  
 
Figure 3. FT-IR spectra of PCL (black) and MPEG-PCL (red) polymer. 
3.4.2. Physicochemical characterization of nanoparticles 
MPEG-PCL nanoparticles have greater potential in drug delivery, it is already used to deliver several drugs with 
good successes rate (Peng et al., 2015; Wang et al., 2014). It is well known that the attachment of PEG in the 
nanoparticle enhances the circulation time and cellular up take of nanoparticles (Jokerst et al., 2011; Vij et al., 
2010). Curcumin or withanolides are hydrophobic agents not soluble in water but when W. somnifera extract 
or curcumin were encapsulated into PCL or MPEG-PCL as nanoparticles, they have shown water solubility, 
suggesting that nanoencapsulation enhances aqueous solubility of the compounds (Figure 4, 7). Poorly water 
soluble drugs often require high doses in order to reach therapeutic plasma concentrations, after oral 
administration. Low aqueous solubility is the major problem encountered by the formulation of new chemical 
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entities as well as generic development. Any drug to be absorbed must be present in the form of an aqueous 
solution at the site of absorption. Water is the solvent of choice for liquid pharmaceutical formulations. Most of 
the drugs are either weakly acidic or weakly basic having poor aqueous solubility (Savjani et al., 2012). Since 
encapsulation of W. somnifera extract or curcumin into PCL or MPEG-PCL nanoparticles increased their water 
solubility, we suggest the usage of these nanoparticles may be a simple way to improve the absorption of any 
non-water soluble compounds. 
3.4.2.1 Characterization of empty nanoparticles 
The PCL and MPEG-PCL empty nanoparticles were prepared and characterized by Particle size, Polydispersity 
index (PDI) and Zeta potential (Table 2).  
Table 2. Particle size, PDI and Zeta potential of Free PCL and MPEG-PCL nanoparticles 
Formulation 
code 
Zeta average size (nm ± 
SD) 
Polydispersity index (PI 
± SD) 
Zeta potential 
(mV ± SD) 
EMP1 210.20±4.24 0.21±0.24 -24.6±2.2 
EMP2 226.12±4.6 0.26±0.30 -36.12±2.1 
EMP3 201.38±3.2 0.32±0.24 -31.10±3.1 
EMP4 204. 32±3.3 0.26±0.16 -32.24±1.6 
EMP5 214. 3.7±3.2 0.20±0.26 -27.14±1.8 
EMM1 54.30±3.60 0.32±0.220 -17.5±0.70 
EMM2 70.12±2.70 0.36±0.146 -15.3±1.22 
EMM3 36.44±1.62 0.34±0.006 -13.5±1.0 
EMM4 31.16±2.19 0.32±0.032 -9.3±1.40 
EMM5 48.60±2.36 0.30±0.0627 -10.7±1.32 
Values are expressed as mean ± standard deviation (n=3). EMP: Empty PCL nanoparticles; EMM: Empty MPEG-PCL 
nanoparticles. 
3.4.2.2. Characterization of W. somnifera extract loaded nanoparticles 
Neuroprotective compounds present in W. somnifera extract were successfully extracted and purified with 
dichloromethane and successfully encapsulated as PCL and MPEG-PCL nanoparticles by solvent displacement 
method. Both prepared nanoparticles were completely dispersed in aqueous media without any aggregates, 
whereas free W. somnifera extract exhibits poor aqueous solubility (Figure 4). 
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Figure  4. Aqueous solubility of W. somnifera extract in PCL nanoparticles (A) MPEG-PCL nanoparticles (B) 
Particle size is an important parameter as it can directly affect the physical stability, cellular uptake, bio-
distribution, and drug release from the nanoparticles. The prepared W. somnifera extract loaded nanoparticles 
were in the range of 214.25±2.3 to 268.32±3.2 nm for PCL nanoparticles, whereas the particles were much 
smaller in the rage of 30.76±1.29 to 62.32±3.7 for MPEG-PCL nanoparticles as shown in table 2. The 
Dynamic light scattering (DLS) characterization of size and size distribution of W. somnifera extract 
encapsulated in PCL and MPEG-PCL nanoparticles are shown in Figure 5. Difference in particle size was 
observed by altering the amount of polymer and stabilizer. The zeta potential value of MPEG-PCL nanoparticle 
(-7.9±1.60 mV) were much smaller compared with PCL nanoparticles (-30.14±2.6 mV) (Table 3). 
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Figure 5. Particles size and distribution of W. somnifera extract loaded PCL nanoparticles (A), Particles size and distribution of W. 
somnifera extract loaded MPEG-PCL nanoparticles (B) 
Table 3. Particle size, PDI, Zeta potential and Entrapment efficiency of W. somnifera extract loaded PCL and 
MPEG-PCL nanoparticles  
Formulation  
code 
Zeta average size 
(nm ± SD) 
Polydispersive index 
 (PI ± SD) 
Zeta potential 
(mV ± SD) 
Entrapment efficiency 
( % ± SD) 
WSEP 1 242.12±3.24 0.31±0.02 -34.2±2.2 39.08 ± 2.15 
WSEP 2 268.32±3.6 0.36±0.20 -32.42±3.1 46.06 ± 3.52 
WSEP 3 240.28±4.2 0.28±0.14 -30. 20±2.1 42.16 ± 2.32 
WSEP 4 214. 25±2.3 0.24±0.26 -30.14±2.6 59.26 ± 3.31 
WSEP 5 224. 2.7±2.3 0.20±0.06 -29.14±2.8 49.21 ± 3.72 
WSEM 1 43.40±2.70 0.30±0.121 -15.3±0.90 46.62 ± 2.82 
WSEM 2 62.32±3.70 0.38±0.152 -14±1.533 53.30 ± 1.21 
WSEM 3 31.24±0.80 0.33±0.009 -12.7±1.20 44.72 ± 3.13 
WSEM 4 30.76±1.29 0.36±0.043 -7.9±1.60 72.82 ± 0.80 
WSEM 5 42.70±2.26 0.32±0.047 -11.9±1.60 54.12 ± 1.20 
Values are expressed as mean ± standard deviation (n=3). WSEP: W. somnifera extract loaded PCL nanoparticles; WSEM: W. 
somnifera extract loaded MPEG-PCL nanoparticles  
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Nanoparticle structure plays an important role in determining their adhesion and interaction with cells. As it 
can be observed in the TEM images of the PCL and MPEG-PCL nanoparticles, they have spherical shape 
(Figure 6).  
 
Figure 6. Characterization of W. somnifera extract loaded PCL and MPEG-PCL nanoparticles. TEM image of W. somnifera extract 
loaded PCL nanoparticles (A), TEM image of W. somnifera extract loaded MPEG-PCL nanoparticles (B). 
The surface of PCL nanoparticles appears to be rough and porous. The pores surface of PCL/Pluronic F68 and 
MPEG-PCL/Pluronic F68 nanoparticles could be attributed to the hydrophilicity of Pluronic F68. The surface 
charge is an important parameter in nanoparticles systems because it can greatly influence particles stability 
(He et al., 2010). It is also an important factor to determine their in vivo interaction with the cell membrane, 
which is usually negatively charged.  
3.4.2.3. Characterization of curcumin nanoparticles 
Curcumin encapsulated PCL and MPEG-PCL nanoparticles were prepared by solvent evaporation method. 
Curcumin and MPEG-PCL were dissolved in acetone then this organic phase was added to an aqueous phase 
containing surfactant.  
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Figure 7. Aqueous solubility of curcumin in PCL nanoparticles (A) MPEG-PCL nanoparticles (B) 
In the structure of MPEG-PCL, PEG is the hydrophilic segment and PCL is the hydrophobic segment, so the 
MPEG-PCL micelles always had a core-shell structure with a PCL core and a PEG shell. Self-assembly of 
curcumin and MPEG-PCL created a core-shell. It is well know that curcumin is not soluble in aqueous medium, 
but the prepared nanoparticles had shown better aqueous solubility (Figure 7). The size distribution of 
curcumin loaded PCL and MPEG-PCL nanoparticles were measured by DLS and the size distribution of the 
nanoparticles are shown in Figure 8.  
 
Figure 8. Preparation and characterisation of curcumin loaded PCL and MPEG-PCL nanoparticles. Particles size and distribution of 
curcumin-PCL nanoparticles (A), Particles size and distribution of curcumin-MPEG-PCL nanoparticles 
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The polydispersity index and zeta potential of particles are important physico-chemical parameters, which 
influence the stability of the polymer. The polydispersity index was determined to be approximately 0.22, 
exhibiting a homogeneous distribution in diameter. Moreover, the lowest zeta potential value (-13.5 mV) of 
these particles enhances their suitability further, compared to other batches. When the particle size of 
curcumin encapsulated PCL and MPEG-PCL nanoparticles were compared with the size of the free PCL and 
MPEG-PCL nanoparticles, a gradual increase in their size could be observed, evidencing of the incorporation of 
curcumin into the nanoparticles.  
The morphology of the nanoparticles was determined by TEM. As seen in the TEM image of curcumin loaded 
PCL and MPEG-PCL nanoparticles (Figure 9), they presented a smooth spherical shape and were within the 
range of 200-250 nm for PCL and 30-70 nm for MPEG-PCL nanoparticles (Table 4). The results obtained from 
particles size analyser correlates with the results obtained from TEM. 
 
 
 
Figure 9. Morphological characterisation of curcumin loaded nanoparticles. TEM image showing spherical shape of curcumin loaded 
PCL nanoparticles (A) and MPEG-PCL nanoparticles (B) 
The average size of the prepared nanoparticles loaded with curcumin ranged between 226-250 nm for PCL 
nanoparticles, whereas, their MPEG-PCL nanoformulations produced much smaller particles in the size rage of 
44-72 nm (Table 4). 
Table 4. Particle size, PDI, Zeta potential and Entrapment efficiency of curcumin loaded PCL and MPEG-PCL 
nanoparticles. Values are expressed as mean ± standard deviation (n=3).  
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Formulation 
code 
Zeta Average Size (nm 
± SD) 
Polydispersity index 
(PI ± SD) 
Zeta potential 
(mV ± SD) 
Entrapment efficiency 
( % ± SD) 
CURP1 250.20±2.4 0.32±0.14 -14.6±2.2 39.08 ± 2.15 
CURP2 243.16±3.2 0.28±0.20 -26.12±2.1 46.06 ± 3.52 
CURP3 232.64±2.6 0.32±0.34 -14.10±3.2 42.16 ± 2.32 
CURP4 224. 28±2.3 0.24±0.26 -22.24±1.6 72.26 ± 3.31 
CURP5 226. 4.7±5.2 0.18±0.16 -17.14±1.8 46.32 ± 2.24 
CURM1 66.40±2.72 0.22±0.242 -16.4±0.52 38.12 ± 3.42 
CURM2 72.22±3.14 0.26±0.136 -13.2±1.32 42.10 ± 2.32 
CURM3 44.24±1.46 0.24±0.018 -11.6±2.4 56.62 ± 4.13 
CURM4 46.18±2.32 0.22±0.012 -13.5±2.10 85.82 ± 1.80 
CURM5 56.26±3.14 0.20±0.062 -13.6±1.12 59.22 ± 2.10 
CURP: curcumin loaded PCL nanoparticles; CURM: curcumin loaded MPEG-PCL nanoparticles 
3.4.3. In-vitro release of W. somnifera extract and curcumin nanoparticles 
In vitro release behavior of W. somnifera extract loaded PCL and MPEG-PCL nanoparticles were carried out in 
PBS (pH 7.4) at 37 °C. Figure 10 shows the release kinetics of W. somnifera extract from PCL and MPEG–
PCL nanoparticles for 7 days.  The free W. somnifera extract released much faster than W. somnifera extract 
loaded PCL and MPEG-PCL nanoparticles. In the first 6 hrs both W. somnifera extract loaded nanoparticles 
showed an initial faster release of 30-40% and this might be due to the drug released from the surface of the 
nanoparticles. In the following period of study 168 hrs, nearly 80% of the total W. somnifera extract was 
released from the PCL and MPEG-PCL nanoparticles. Both WES nanoparticles showed features of controlled 
release pattern.  
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Figure 10. Drug release profile of free W. somnifera extract (WSE), WSE loaded PCL (WSE PCL NPs) and WSE loaded MPEG-PCL 
(WSE MPEG-PCL) nanoparticles 
The release profile of free curcumin and curcumin from PCL and MPEG-PCL nanoparticles was studied in vitro, 
and the results are shown in Figure 11.  
  
Figure 11. In-vitro drug release profile of curcumin from PCL and MPEG-PCL nanoparticles. 
Approximately 70% of curcumin was released to the media in free curcumin in 24 hrs, whereas by then, only 
26% of the encapsulated curcumin was released from curcumin nanoparticles. Both the PCL and MPEG-PCL 
nanoparticles exhibited initial burst release followed by a slower sustained release pattern. The initial burst 
release might be attributed to the diffusion of curcumin from PCL or MPEG-PCL nanoparticles. For instance 
curcumin MPEG-PCL nanoparticles attained more sustained release compared with PCL nanoparticles. The 
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controlled release pattern of WES and curcumin PCL and MPEG-PCL nanoparticles might help to achieve 
better pharmacological dynamics and kinetics.   
3.4.4. Differential scanning calorimetry (DSC) analysis for W. somnifera extract and Curcumin nanoparticles 
DSC analysis was performed to know the physical nature of the drug in the nanoparticles. The DSC is an 
accurate and rapid thermo analytical technique, widely used by the pharmaceutical industry and in drug 
research, to investigate several physicochemical phenomena, such as polymorphism, melting and 
crystallization, purity, drug–excipient interaction, polymer properties. The DSC chromatogram of W. somnifera 
extract shows the melting endothermic peak at 111.26 °C (Figure 12). However, no melting peak was 
detected for both PCL and MPEG-PCL nanoparticle formulations, evidencing the absence of crystalline drug in 
the nanoparticles, at least at the particle surface level. Therefore, it could be concluded that W. somnifera 
extract in the nanoparticles was in an amorphous or disordered crystalline phase of a molecular dispersion or 
a solid solution state in the PCL/Pluronic F68 and MPEG-PCL/Pluronic F68 matrix after its production. 
  
Figure 12. Differential scanning calorimetric thermo gram of W. somnifera extract (WSE) loaded PCL and MPEG-PCL nanoparticles. 
Free curcumin had an endothermic melting peak at 178.59 0 C implying its crystalline state of curcumin 
(Ghosh et al., 2014). This peak was absent in the thermo gram of curcumin-loaded PCL and MPEG-PCL 
nanoparticles, which only exhibited the characteristic melting peaks of MPEG-PCL around 55.52 0C (Figure 13). 
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Figure 13. Differential scanning calorimetric thermo gram of PCL and MPEG-PCL loaded curcumin nanoparticles 
The absence of detectable crystalline domains of curcumin in the loaded particles indicates that encapsulated 
curcumin was in the amorphous form in the polymeric matrix. The presence of drug in crystalline form inside 
nanoparticles can be an obstacle due to the difficulty in the diffusion of large-sized molecules from the small 
pores of the nanoparticles. However, a sustained release of the encapsulated drug is possible if the drug is in 
amorphous phase, as it facilitates easy diffusion of drug molecules through the polymeric matrix. 
3.4.5. X-ray diffraction (XRD) analysis for W. somnifera extract and curcumin nanoparticles 
The overlaid XRD pattern of MPEG-PCL, W. somnifera extract, W. somnifera extract loaded PCL and MPEG-PCL 
nanoparticles is shown in Figure 14. The XRD pattern of W. somnifera extract exhibited diffraction peaks at 2 
value of 22.40 indicating their crystalline nature.  The characteristic crystalline peaks of W. somnifera extract 
was absent in the patterns of WSE loaded PCL and MPEG-PCL nanoparticles suggesting the amorphous state 
of nanoparticles. Whereas, the XRD pattern of physical mixture diffraction peaks of MPEG-PCL and W. 
somnifera extract reveals an incomplete dissolution and the existence of a crystalline state of W. somnifera 
extract in the polymer. 
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Figure 14. X-ray diffraction patterns of MPEG-PCL, W. somnifera extract (WSE), physical mixture and WSE loaded PCL and MPEG-PCL 
nanoparticle 
To examine the crystallinity of nanocurcumin, XRD analysis was carried out. XRD studies on pure curcumin, 
MPEG-PCL and curcumin-loaded PCL and MPEG-PCL nanoparticles was performed using an X-ray 
diffractometer (Philips, PW1710) with a horizontal goniometer. The samples were placed in the sample holder 
and scanned at a rate of 1° min -1 from 0° to 60°.  MPEG-PCL exhibit diffraction peaks at 2 value of 19.2°, 
21.4° and 23.5° (Figure 15).   
.  
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Figure 15. X-ray diffraction patterns of MPEG-PCL, physical mixture, curcumin and curcumin loaded PCL and MPEG-PCL 
nanoparticles 
By comparing the XRD patterns of curcumin and curcumin loaded nanoparticles, it was found that the 
characteristic crystalline peaks of curcumin was absent in the patterns of curcumin-loaded PCL and MPEG-PCL 
nanoparticles, which suggests that curcumin was molecularly dispersed and there is no curcumin crystals in 
the nanoformulations. So it is concluded that the encapsulated curcumin was in amorphous state. 
The noticed difference in the particles size between the free and W. somnifera extract or curcumin 
encapsulated nanoparticles is a proof that W. somnifera extract or curcumin has been loaded into the polymer 
matrix. When compare with PCL nanoparticles the MPEG-PCL nanoparticles were much smaller in size and 
this is probably due to the amphiphilic nature of the polymer.  Zeta potential is a physical property present in 
any particle in dispersion and it is an indirect measurement of the surface charge (Malvern, 2012). Surface 
charge is important in determining whether the nanoparticles will cluster in blood flow or will adhere to or 
interact with oppositely charged cell membrane (Danafar et al., 2014; Kumari et al., 2010). Our curcumin 
encapsulated MPEG-PCL nanoparticles showed the surface charge range between -11 to 16, which indicates 
higher stability of the nanoparticles. A successful nano carrier system is the one which has the higher 
entrapment efficacy to reduce the quantity of the carrier required for administration. In our study we got 
85.82% of entrapment efficacy for MPEG-PCL nanoparticles.  
Conventional oral drug administration does not usually provide rate-controlled release or target specificity. In 
many cases, conventional drug delivery provides sharp increases of drug concentration at potentially toxic 
levels. In our experiments free W. somnifera extract released in the PBS faster in such a way that within 48 hrs 
90% of W. somnifera extract release was achieved, when converted as nanoparticles W. somnifera extract was 
released in a controlled manner. This is an added advantage of nanoencapsulation. 
3.5. Conclusion 
Although, phytomedicines possess excellent in-vitro bioactivity, the poor aqueous solubility, larger molecular 
size and extensive metabolism limits their clinical outcome. Application of nanotechnology for phytomedicine 
increases their bioavailability and bioactivity by reducing the size of the particles and surface modification. 
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Nanomaterials aids the targeted delivery, sustained delivery and improves the pharmacokinetics profile, 
diffusion of drugs into various organs by crossing the barriers including the blood brain barrier. In this study we 
have prepared W. somnifera extract (containing the bioactive compounds of W. somnifera) and curcumin 
encapsulated PCL and MPEG-PCL nanoparticles by solvent displacement method. The size of these 
nanoparticles was influenced by polymer drug ratio. The prepared nanoparticles were spherical in shape with a 
smooth surface. The hydrophobicity of W. somnifera extract or curcumin was overcome by nanoencapsulation. 
Furthermore, the prepared nanoparticles can be administered parentally because of their smaller size and 
biodegradability of the polymer. 
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4. In vitro and in vivo assays with W. somnifera extract and curcumin loaded nanoparticles  
4.1. Abstract 
Polymeric nanoparticles prepared and characterized as described in the previous section were evaluated for their 
cellular uptake, cytotoxicity and neuroprotection in U251 glioma cells In-vitro neuroprotective effect was analyzed 
against tert-Butylhydroperoxide (tBHP) induced oxidative damage and in-vivo localization was assessed in 
Zebrafish. In vitro cytotoxicity assay with U251 human glioma cells showed that the empty (PCL and MPEG-PCL) 
nanoparticles were nontoxic to the cells up to 500 µg/ml. Treatment of U251 giloma cells with PCL and MPEG-
PCL nanoparticles loaded with curcumin or W. somnifera extract revealed efficient cellular uptake. The cellular 
uptake of MPEG-PCL nanoparticles were higher compare to PCL nanoparticles. The in-vivo localization of 
nanoparticles in  Zebrafish model suggested that the MPEG-PCL nanoencapsulation of WSEC (W. somnifera 
extract co-encapsulated with coumarin-6 for localization study) or curcumin had efficient delivery compared with 
the free drug (W. somnifera extract or curcumin) or loaded in PCL nanoparticles. Moreover, MPEG-PCL di-block 
copolymer loaded W. somnifera extract or curcumin nanoparticles was able to protect the cells against tBHP 
induced oxidative damage in a superior way compared to free W. somnifera extract or curcumin. Together, our 
results show that W. somnifera extract or curcumin loaded MPEG-PCL di-block copolymer nanoparticles possess 
significantly higher neuroprotective effect in U251 human glioma cells compared to the free drugs and W. 
somnifera extract or curcumin encapsulated in PCL nanoparticles. 
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4.2. Introduction  
Medicines derived from plants have played a crucial role in the health care of many cultures of the human history 
(Gong et al., 2013). Herbal medicine has been used as a remedy for neurological disorders for more than a 
century and the initial drugs used to treat pathologic conditions of the CNS were based on natural resources 
specifically from plants (Gomes et al., 2009). After the isolation of active constituents, such as morphine from 
Opium species, the scientific understanding of psychoactive plants has advanced significantly (Sarris et al., 2011). 
In this context, bio-active compounds from Hypericum perforatum (St. John's wort) is another good example for 
the potential of herbal medicine. Extract/compounds of H. perforatum are well recognized in the treatment of mild 
to moderate depression today in several countries. Recently, it is proven that the bioactive compound from this 
plant increases the neuroprotective activity and memory in diabetic rats (Hasanein and Shahidi, 2011) 
W. somnifera a well-known medicinal plant in Indian ayurvedic medicine, is distributed throughout India. Due to 
the high medicinal value and nontoxic property of this plant referred as Indian ginseng. The major biochemical 
constituents of W. somnifera are steroidal alkaloids and lactones, together known as withanolides (Ganzera et al., 
2003). The isolated bioactive constituent as well as extract of this plant has been reported to possess 
adaptogenic, anticancer, anti-convulsant, immunomodulatory, anti-oxidative and neurological effects (Chatterjee et 
al., 2010). Similar to W. somnifera, Curcuma longa in general, and its natural compound curcumin in specific has 
been used as a traditional therapeutic agent in Asian medicine to treat various common ailments (Gregory et al., 
2014b). Curcumin has been used as food pigment in India and China. It is highly pleiotropic molecule able to 
interact with large number of molecular target and particularly safer even at higher doses (8g/day) (Gupta et al., 
2013). Recent studies have shown that curcumin exhibit multiple pharmacological activities, including anti-
inflammatory (Zhang et al., 2015), antioxidant (Motaghinejad et al., 2015), anti-bacteria, anti-virus, and 
hyperlipidemic activities (Egan et al., 2004).  
Although, several studies have explored the pharmacological importance of W. somnifera extract and curcumin, 
their clinical application has been hindered due to several issues. For instance, poor aqueous solubility of W. 
somnifera extract and curcumin leads to the poor cellular uptake, bioavailability that limits the in-vivo 
pharmacokinetics (Jagetia and Aggarwal, 2007). Hence, we have developed W. somnifera extract or curcumin 
loaded PCL and MPEG-PCL nanoparticles that showed improved water solubility and sustained release profile 
compared to the free forms. In this study, we have analyzed the cellular uptake and protective effect of those 
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nanoformulations against tBHP induced oxidative stress in U251 glioma cells. Though there are a number of 
studies focusing on in vitro evaluation of nanoparticles, studies related to in vivo toxicity is scarce. In this context, 
Danio rerio (Zebrafish) is currently emerging as an excellent model. Zebrafish is a small benthopelagic tropical 
freshwater fish, native from India and Southeast Asia. The advantages of using Zebrafish for experimental 
bioassays include its size, robustness, short life cycle, high fecundity and potential to easily breed in captivity. 
Hence, in addition to in vitro assays, we have also performed in vivo assays with Zebrafish model for evaluate the 
localization of nanoparticles. 
4.2. Methods and materials 
4.2.1 Cell culture 
Human glioblastoma-astrocytoma epithelial-like cell line (U251) was obtained from the faculty of Pharmacy, 
University of Porto. Cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 1% 
streptomycin, 10% fetal bovine serum (FBS) and incubated in a carbon dioxide incubator (5% CO2) at 37 °C. 
4.2.2 Cytotoxicity Assay 
The effect of W. somnifera extract and curcumin in the free form and in the form of nanoparticles on cell 
proliferation was determined using MTT assay. Briefly, U251 cells were plated onto 24-well flat-bottom plates at a 
concentration of 104 cells per well (Orange Scientific products, Belgium) with standard culture medium. After 24 
hrs of incubation at 37 °C, the culture medium was removed and replaced with 500 µl of fresh culture medium 
augmented with different concentrations of W. somnifera extract and curcumin in the free form and as 
nanoparticles (PCL and MPEG-PCL). To check the influence of polymer, empty PCL and MPEG-PCL nanoparticles 
were added to the cells in separate experiments. After 48 hrs of treatment, culture medium containing free drugs, 
drug loaded nanoparticles and empty nanoparticles were removed and replaced with 500 µl of fresh culture 
medium containing MTT (0.5 mg/ml in Krebs medium, pH.7.4) and further incubated under similar conditions for 
another 4 hrs. After the 4 hrs incubation, MTT solution was discarded from the wells and 500 L of DMSO: 
ethanol (1:1) was added and the plates were shaken for 10 min at room temperature under dark in order to 
solubilize any formazan crystals formed by the reaction. The absorbance of the formazan solution from varios 
treatments was measured at 570 nm using a microplate reader (Synergy™ H Multi-mode Microplate Reader, 
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BioTek Instruments, USA). The amount of MTT that is converted to formazan after incubation with cells 
corresponds to the number of viable cells.  
4.2.3. In-vitro cellular uptake of nanoparticles 
Human glioma cells (U251) were seeded in 24-well plates with standard culture medium and allowed to attach 
and grow. After 24 hrs, cells were co-incubated with 0.5 ml of (5 µg/ml) coumarin- 6 loaded PCL and MPEG-PCL 
nanoparticles. After different periods of incubation (2, 4 and 24 hrs), cells were washed three times in phosphate 
buffer saline (PBS) to eliminate any PCL or MPEG-PCL nanoparticles that were not up taken by the cells. Then, the 
cells were fixed in paraformaldehyde and their nuclei were stained in Hoechst dye and photographed under a 
fluorescent microscope equipped with photography (Olympus 1X71). In the same manner, the cellular uptake of 
curcumin loaded PCL and MPEG-PCL nanoparticles were analyzed. 
4.2.4. Neuroprotection assay 
To evaluate the effect of t-BHP in U251 cells we have tested various concentrations of tBHP (100 µM, 0.25, 0.5 
and 1mM) and different periods of incubations (1, 2 and 3 hrs). For the neuroprotection study, an optimized 
concentration (1mM) of tBHP that could induce oxidative damage to the cells was added together with different 
concentrations of W. somnifera extract or curcumin loaded PCL and MPEG-PCL nanoparticles. The percentage of 
neuroprotection is calculated by the following equitation. 
% of neuroprotection = % of Cell Viability Ext +ins -% of Cell Viability ins 
Whereas, 
Cell Viability Ext +ins = % of cell viability with tBHP, and nanoparticles, relatively to the control cells 
Cell Viability ins = % of cell viability with tBHP, relatively to the control 
4.2.5. In-vivo localization of nanoparticles in Zebrafish 
Zebrafish eggs were collected from adult fish bred under standardized conditions and the eggs were observed with 
a stereo microscope (Nikon Eclipse TS 100) to select healthy embryos. The selected eggs were washed twice with 
water and incubated at 25° C for 80 hrs in order for them to develop into larval stage and these larvae were used 
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for the localization experiment. Briefly, 10 healthy embryos were transferred into each well of a 24 well 
polystyrene multi well plate in quadruplicate. Two different concentrations (0.25 and 1 µg/ml) of both PCL and 
MPEG-PCL nanoparticles loaded with W. somnifera extract and curcumin were tested. After adding the 
nanoparticles, the plate was incubated for 80 hrs at 28.5 °C. The development of Zebrafish was observed for the 
next 80 hrs and the images were recorded under a florescent microscope (Olympus IX71, Hamburg, Germany). 
4.2.6. Statistical analysis 
All experimental parameters were analyzed statistically and graphs were generated using GraphPad 5 software 
(Prism, USA). Results are expressed as the mean ± standard error of the indicated number of experiments. The 
significance of the differences between the means was evaluated using the unpaired two-tailed Student’s t-test. A 
difference of p≤0.05 between values was considered significant. 
4.3. Results and discussion 
4.3.1. In vitro cytotoxicity of empty nanoparticles 
The MTT colorimetric assay is a well-established method for determining the cytotoxic effect of substances 
(Sylvester, 2011). Since it is important to know whether an eventual the cytotoxic effect is from the polymer or 
from the drug, first we have studied the cytotoxicity of empty nanoparticles at different concentrations (1, 10, 50, 
100, 500 µg). As shown in Figure 1, it is clear that both  PCL and MPEG-PCL empty nanoparticles were not 
significantly toxic up to 500 µg/ml.  It should be noted that PCL and MPEG-PCL are non-toxic, biodegradable and 
biocompatible polymers, which are approved by U.S. Food and Drug Administration (FDA). 
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Figure 1. In- vitro cytotoxicity of empty nanoparticles in U251 glioma cells (1×104 density). 
4.3.2. In- vitro cytotoxicity of W. somnifera extract and curcumin  
Among the different concentrations of W. somnifera extract tested, the lower concentrations (0.1, 1 and 10 
µg/ml) did not affect the cell viability and remained similar to the control cultures. On the other hand, W. 
somnifera extract concentration at 25 µg/ml and above showed significant reduction in cell viability compared to 
control (Figure 2).  
 
Figure 2. Cytotoxicity of W. somnifera extract (WSE) in U251 human glioma cells. Statistical analysis of the data was performed using 
one sample T-test. Asterisks (*) denotes statistically significant difference from control (only cells) ( **P<0.01, ***P<0.001).  
Similar to the W. somnifera extract, cytotoxic effect of free curcumin was also tested by MTT assay. From previous 
reports, we found that above 25 µg/ml of curcumin is cytotoxic, so we tested until the maximum concentration of 
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25 µg/ml.  Among the different concentration of curcumin tested, 25 µg/ml showed significant reduction in cell 
viability compare to the control (Figure 3). As observed in the case of W. somnifera extract, lower concentrations 
of curcumin such as 0.1, 1, 5, and 10 µg/ml did not affect cell viability significantly and remained similar to the 
control. 
 
Figure 3. Cytotoxicity of curcumin in U251 human glioma cells (1×104 density). Statistical analysis of the data was performed using 
one sample T-test. Asterisks (*) denotes statistically significant difference from control (only cells) ( **P<0.01, ***P<0.001).  
From these results it is clear that W. somnifera extract and curcumin inhibit cells viability in a concentration 
dependent manner.   
4.3.3. In-vitro cytotoxicity W. somnifera extract and curcumin loaded nanoparticles  
As observed for free W. somnifera extract, 25 µg/ml of W. somnifera extract loaded PCL and MPEG-PCL 
nanoparticles significantly inhibited the viability, whereas the lower concentrations (0.1, 1 and 10 µg/ml) did not 
show any sign of toxicity of cells compared to control. Similar to free WSE, nanoparticles loaded with W. somnifera 
extract also inhibited cell viability in a dose dependent manner (Figure 4A). On the other hand, 10 µg/ml and 25 
µg/ml concentrations of curcumin loaded PCL and MPEG-PCL nanoparticles showed significant reduction in cell 
viability compared to control (Figure 4B). Approximately 50% inhibition of cell viability was observed at 25 µg/ml 
concentration of curcumin delivered in the form of PCL and MPEG-PCL encapsulated nanoparticles. When the 
other concentrations of curcumin loaded PCL and MPEG-PCL nanoparticles (0.01, 0.1, and 1 µg/ml) were 
employed, the numbers of viable cells were almost similar to the control and the small variations observed with 
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these concentrations are not statically significant. Hence 0.1, 1 and 10 µg/ml of W. somnifera extract and 
curcumin encapsulated PCL and MPEG-PCL nanoparticles were chosen for further assays regarding 
neuroprotection.  
  
Figure 4. (A) Cytotoxicity of W. somnifera extract (WSE) loaded PCL and MPEG-PCL nanoparticles in U251 human glioma cells (1×104 
density). Data presented (mean ± SD, n = 3). (B) Cytotoxicity of curcumin nanoparticles in U251 human glioma cells. Data presented 
(mean ± SD, n = 3). Statistical analysis of the data was performed using one sample T-test. Asterisks (*) denotes statistically significant 
difference from control (only cells) (***P<0.001).   
4.3.4. In-vitro cellular uptake of W. somnifera extract or curcumin nanoparticles 
4.3.4.1 In-vitro cellular uptake of W. somnifera extract loaded nanoparticles 
The intracellular uptake of W. somnifera extract loaded PCL and MPEG-PCL nanoparticles were studied by using 
coumarin-6 co-encapsulation with W. somnifera extract (WSEC) (Gao et al., 2013). As seen in Figure 5, cells 
treated with WSEC loaded MPEG-PCL nanoparticle showed profound fluorescence intensity compared to the cells 
incubated with the similar PCL nanoparticles at equivalent concentration (10 µg/ml), indicating that the WSEC 
loaded MPEG-PCL nanoparticles should have been up taken more effectively than that of PCL nanoparticles. 
Compared to the free WSEC, its PCL and MPEG-PCL nanoformulations were up taken by the glioma cells as less 
as in 2 hrs. Plausibly, the cells must have up taken the particles through endocytosis, which had been confirmed 
in many other in vitro and in vivo studies (Carroll et al., 2010; Ding et al., 2011).  
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Figure 5. Human glioblastoma cells (U251) incubated with WSEC loaded PCL and MPEG-PCL nanoparticles for different time durations 
(2, 4, and 24 hrs). After treatments, the cells were analyzed for their fluorescence intensity under fluorescence microscope. Fluorescent 
images of free WSEC (A), WSEC loaded PCL nanoparticles (B) and WSEC loaded MPEG-PCL nanoparticles (C) showing the internalization 
of nanoparticles by the U251 human glioma cells.  
 
4.3.4.2. In-vitro cellular uptake of curcumin encapsulated nanoparticles 
Curcumin is an auto fluorescent compound that emits a green fluorescence when viewed under a 535–600 nm 
filter (Ucisik et al., 2013). Following 4, 6 and 24 hrs of treatments of U251 cells with free curcumin and curcumin 
loaded PCL or MPEG-PCL nanoparticles, the green fluorescence intensity increased in a time-dependent manner. 
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While cells incubated with free curcumin failed to register any fluorescence even after 24 hrs, the cells treated 
with curcumin nanoparticles showed fluorescence, indicating that nanoformulation always improves the cellular 
uptake of curcumin. Maximum fluorescence intensity for each treatment was observed in cells that were 
undergone 24 hrs co-incubation. MPEG-PCL nanoparticle treated cells showed the highest intensity of 
fluorescence compared to PCL nanoparticles (Figure 6 A, B and C), clearly revealing the importance of MPEG 
conjugation for highest cellular uptake of nanoparticles. Interestingly, the fluorescence signal displayed by 
curcumin loaded PCL nanoparticles was more superficial and lighter than the one generated by curcumin-MPEG-
PCL, suggesting that the superficial signal might be from the nanoparticles attached to the surface of the cells and 
the lighter intensity could be because of curcumin dispersed in the cytoplasm rather than accumulated in the 
nuclei. On the other hand, cells treated with curcumin-MPEG-PCL NPs showed fluorescence not only in the 
cytoplasm but also in the nuclei, overall increasing the intensity of fluorescence. Since, MPEG-PCL nanoparticles 
had shown higher amount of fluorescent intensity, we conclude that the attachment of MPEG to PCL has 
increased the cellular uptake of particles. Overall, curcumin in the form of MPEG-PCL nanoparticles is an efficient 
way to penetrate cells and get into the cytoplasm and nucleus. 
  
Chapter 4                                                         In- vitro cellular uptake and in-vivo localization of nanoparticles 
 
98 
 
 
Figure 6. Human glioblastoma cells (U251) incubated with curcumin solution, and curcumin loaded PCL and MPEG-PCL nanoparticles 
for different time periods (4, 6 and 24 hrs) were analyzed for their fluorescence intensity under fluorescence microscope. Fluorescent 
images of free curcumin (A), curcumin loaded PCL nanoparticles (B) and curcumin loaded MPEG-PCL nanoparticles (C) showing the 
internalization of nanoparticles by the U251 human glioma cells.  
 
4.3.5. Neuroprotective effect of W. somnifera extract and curcumin PCL and MPEG-PCL nanoparticles 
Neurodegenerative diseases are multifactorial pathogenesis characterized by the deregulation of several pathways 
(Sheikh et al., 2013). Genetic, environmental and endogenous factors related to aging contribute to 
neurodegeneration, but their pathogenic role and their basic molecular mechanisms are not fully understood 
(Jellinger, 2010). Free radical mediated injury is known to play a major role in the disease process of ischemic, 
traumatic, and degenerative disorders in the CNS (Uttara et al., 2009). Therapeutic agents that can target 
multiple pathophysiological mechanisms can be extremely useful to protect the neuronal cells from damage. Thus 
a special emphasis was given to test the effect of our nanoformulations on oxidative stress was undertaken. 
4.3.5.1. Effect of tBHP concentration in U251 glioma cells 
Tert-butyl hydroperoxide (tBHP) is a ROS generating agent that causes lipid peroxidation, which is used as a 
model substance for the induction of oxidative damage to the cells (Dumont et al., 2002). tBHP has been known 
to decrease cellular proliferative life span and increase the proportion of cells’ positive senescence-associated 
enzyme activity (Shin et al., 2009). Thus, tBHP is known for the induction of oxidative stress-induced premature 
senescence.  
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Neurons are particularly rich in polyunsaturated fatty acids, which make neurons more susceptible to oxidative 
stress than other cells. tert-Butyl hydroperoxide (tBHP) is commonly used to induce oxidative stress in numerous 
cell lines including neurons (Hughes et al., 2014). In order to optimize tBHP concentration that could induce 
oxidative damage in the cells, we have analysed a range of concentrations of tBHP (100 µM, 0.25 mM, 0.5 mM 
and 1 mM) with different time period of incubation (Figure 7). Our results revealed that 1mM tBHP induced 
optimum oxidative damage to the U251 glioma cells upon 3 hrs incubation. Hence, 1mM tBHP concentration and 
incubation time of 3 hrs were selected for further neuroprotection experiments. 
.  
Figure 7. Cell viability analysis by MTT reduction test. U251 cells were incubated with different concentrations of tBHP (100 µM, 0.25, 
0.5 and 1mM) for different time period (1, 2 and 3 hrs). Note: 1mM tBHP treatment results in 50% viability reduction in U251 cells upon 
3 hrs incubation. 
4.3.5.2. Neuroprotective effect of W. somnifera extract loaded PCL and MPEG-PCL nanoparticles  
Three different concentrations (0.1, 1 and 10 µg/ml) of W. somnifera extract, equivalent W. somnifera extract 
loaded PCL and MPEG-PCL nanoparticles and both PCL and MPEG-PCL empty nanoparticles were analyzed for 
their neuroprotective potential. Empty nanoparticles did not show any protective effect against oxidative damage, 
when compared with control cells (Figure 8). However, W. somnifera extract and W. somnifera extract loaded 
nanoparticles significantly protected neuronal cells against oxidative damage induced by tBHP (Figure 8 A, B and 
C). When compared with the free W. somnifera extract, nanoparticles loaded with W. somnifera extract showed 
better protective effect. Among the nanoparticle formulations, W. somnifera extract loaded MPEG-PCL 
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nanoparticles showed higher percentage of neuroprotection (42.2%) for 0.1 µg/ml, (88.8%) for 1 µg/ml and 
(95.2%) for 10 µg/ml. Comparatively, W. somnifera extract loaded PCL nanoparticles showed less neuroprotective 
effect of (33.2%) for 0.1 µg/ml, (48.2%) for 1 µg/ml and (56.5 %) for 10 µg/ml respectively. 
 
 
 
Figure 8. Neuroprotective effect of W. somnifera extract (WSE) at different concentrations (0.1 µg/ml, 1 µg/ml and 10 µg/ml) loaded 
MPEG-PCL and PCL nanoparticles upon 1mM tBHP induced oxidative stress in U251 glioma cells. Data presented (mean ± SD, n = 3). 
Statistical analysis of the data was performed using non parametric T-test. Asterisks (*) denotes statistically significant difference from 
free WSE ( **P<0.01, ***P<0.001).  
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As revealed in this experiment (Figure 8), free W. somnifera extract could provide neuroprotection to U251 cells 
against tBHP induced oxidative stress. However, this protection was less effective compared to the equivalent 
amount of its nanoformulation at all concentrations tested. Particularly, these nanoparticles could protect cells 
from oxidative damage even at lower doses and this property could be attributed to their water solubility and 
increased cellular uptake. The protective effect of W. somnifera extract nanoparticles seen in the above conditions 
may be due to the enhanced transport of nanoparticles into glial cells and the sustained release of withanolides, 
contributing to a suitable concentration of withanolides to neutralize the free radicals formed in neuronal cells. 
Previous reports also supports the current findings not only in terms of cellular uptake efficiency, but also 
protection of cells by drug-loaded nanoparticles in several models. Doggui and co-workers reported that packing of 
curcumin into a PLGA nanoparticles increased its protective effect in neurons against oxidative damage caused 
upon Alzheimer's disease (Doggui et al., 2012). Tiwari and their group reported on the improved neuroprotective 
efficacy of nicotine encapsulated PLGA nanoparticles by enhancing the bioavailability of nicotine and subsequent 
modulation in the indicators of oxidative stress and apoptosis (Tiwari et al., 2013). Similarly, loading of sesamol in 
solid lipid nanoparticles is reported as an effective strategy to mitigate intra cerebroventricular  streptozotocin 
induced neuronal dysfunction and memory deficits (Sachdeva et al., 2015). 
4.3.5.3. Neuroprotective effect of curcumin loaded PCL and MPEG-PCL nanoparticles  
Neuroprotective effect of curcumin and curcumin loaded PCL and MPEG-PCL nanoparticles was analyzed against 
1mM tBHP induced oxidative stress in U251 cells. Three different concentrations (0.1 µg/ml, 1 µg/ml and, 10 
µg/ml) of curcumin, equivalent curcumin encapsulated PCL and MPEG-PCL nanoparticles were co-incubated with 
the oxidant agent, tBHP for 3 hours. Empty PCL and MPEG-PCL nanoparticles were also tested in the same 
manner.  
Both PCL and MPEG-PCL empty nanoparticles did not show any protective effect against the induced oxidative 
stress. As expected, bothe curcumin and curcumin loaded nanoparticles showed significant neuroprotection 
against oxidative damage induced by tBHP (Figure 9). When compared with free curcumin nanoparticles showed 
better protective effect. However, there was a difference between the nanoformulations in terms of protection. 
Curcumin delivered in the form of MPEG-PCL encapsulated nanoparticles showed higher percentage of protection 
(79.81%, 84.57% and 37.27% respectively at 0.1 µg/ml, 1 µg/ml and 10 µg/ml concentrations) than equivalent 
PCL nanoparticles (52.87%, 38.63% and  24.03% respectively at 0.1 µg/ml, 1 µg/ml and 10 µg/ml). 
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Interestingly, the neuroprotective effect of both the free and nanoformulations of curcumin was reducing with 
increasing concentrations, suggesting that this compound is more effective as antioxidant at very low 
concentrations.  
 
Figure 9. Neuroprotective effect of different concentrations of curcumin loaded MPEG-PCL and PCL nanoparticles (0.1 µg/ml, 1 µg/ml 
and 10 µg/ml) against tBHP induced oxidative stress in U251 glioma cells. Data presented (mean ± SD, n = 3). Statistical analysis of the 
data was performed using non parametric T-test. Asterisks (*) denotes statistically significant difference from free curcumin (*P<0.05, 
**P<0.01, ***P<0.001).  
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Although many studies have been reported on the effectiveness of curcumin nanoformulations against cancer cell 
lines, studies pertaining to neuroprotection are very limited. Our study reveals that neuroprotective and antioxidant 
activities of curcumin could be improved by nanoencapsulation. Curcumin encapsulated in nanoparticles provide 
neuroprotection from tBHP induced oxidative stress at very low concentration probably due to the enhanced 
transport of curcumin into cells and the sustainable release of antioxidants from nanoparticles, which should have 
contributed to a suitable concentration of curcumin to neutralize the free radicals formed in glioma cells. Improved 
activity of curcumin as nanoformulations has been previously reported. For instance, the cellular uptake of 
curcumin improved when it was prepared as cationic chitosan/PCL nanoparticles (Liu et al., 2012). Recently, 
curcumin was successfully encapsulated into polymeric nanoparticles and nanocurcumin showed grater result 
than free curcumin against different cancer cell lines (Mohanty and Sahoo, 2010).  
4.4. In-vivo localization of W. somnifera extract and curcumin nanoparticles in Zebrafish 
Zebrafish has been recognized widely as a model species for developmental biology, gerontology assessment, 
behavioral ecology, genetics research, and ecotoxicology (Berry et al., 2007). Zebrafish embryos are transparent 
which permits the imaging of internal organs, easy to assess any alterations. Because of its similarity with human 
development and at the level of genes, Zebrafish is highly appreciated as a model system to study early 
development and human diseases. More recently, it has caught the attention of researcher as a perfect model for 
large scale toxicology screenings. Taking advantage of optically clear Zebrafish embryos, in this study we have 
utilized this animal model to visualize the internalization nanoparticles in vivo.  
4.4.1. In-vivo localization of nanoparticles in Zebrafish 
Animals treated with water (Control) and empty nanoparticles did not show any fluorescence throughout the study 
period (Figure 10 A-F). On the other hand, the animals treated with free WSEC and WSEC loaded nanoparticles 
showed faint green fluorescence (Figure 10 G-L). Fluorescence intensity of animals treated with WSEC loaded 
MPEG-PCL nanoparticles was significantly higher compared to coumarin-6 loaded PCL nanoparticles and free 
coumarin (Figure 10 K-L). Importantly, WSEC nanoparticles were distributed uniformly throughout the animal. 
Collectively, our results indicate that MPEG-PCL nanoencapsulation is highly efficient in terms of Zebrafish uptake. 
The amphiphilic nature, smooth surface and uniform size of MPEG-PCL nanoparticles might have facilitated its 
effective uptake by the animals (Shen et al., 2015). As it was reported before, PEG has been used as agent for 
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bacterial/yeast transformation (Karas et al., 2013). In this context, PEGylation could have enabled brain 
permeability, allowing the accumulation of MPEG-PCL nanoparticles inside the  central nervous system more than 
PCL nanoparticles. It is rational to think that more the uptake of drug loaded nanoparticles, better the 
neuroprotective activity. 
 
 
 
Figure 10. Accumulation of W. somnifera extract and coumarin-6 co-encapsulated (WSEC) nanoparticles in 80 hrs old Zebrafish larvae. 
The images were taken after 4 hrs of incubation with free WSEC and WSEC loaded nanoparticles. Light-fluorescent microscopic views of 
control Zebrafish (A-B). Light-fluorescent microscopic views of Zebrafish incubated with empty PCL nanoparticles (C-D). Light-fluorescent 
microscopic views of Zebrafish incubated with empty MPEG-PCL nanoparticles (E-F). Light-fluorescent microscopic views of Zebrafish 
incubated with free WSEC (G-H). Light-fluorescent microscopic views of Zebrafish incubated WSEC loaded PCL nanoparticles (I-J). Light-
fluorescent microscopic views of Zebrafish incubated with WSEC loaded MPEG-PCL nanoparticles (K-L).  
 
4.4.2. In-vivo localization of curcumin nanoparticles 
Localization of curcumin in the free and nanoparticle forms (PCL and MPEG-PCL) were analyzed in Zebrafish 
larvae as described above. No fluorescence was detected in the animals treated with water (Control) and empty 
nanoparticles (Figure 11 A-F). The animals treated with free curcumin and curcumin loaded PCL nanoparticles 
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showed very low level of fluorescence (Figure 11 G-J). However, the fluorescence intensity was significantly higher 
in the animals treated with curcumin loaded MPEG-PCL nanoparticles compared to free curcumin and its PCL 
formulation (Figure 11 K-L). Moreover, as seen in the Figure 11L, the MPEG-PCL nanoparticles were distributed 
uniformly throughout the animal.    
 
 
Figure 11. Accumulation of curcumin nanoparticles in 80 hrs developed Zebrafish larvae. The images were taken after 4 hrs incubation 
with free curcumin or curcumin loaded nanoparticles. Light and fluorescent microscopic views of control Zebrafish (A-B). Light and 
fluorescent microscopic views of Zebrafish incubated with empty PCL nanoparticles (C-D). Light and fluorescent microscopic views of 
Zebrafish incubated with empty MPEG-PCL nanoparticles (E-F). Light and fluorescent microscopic views of Zebrafish incubated with free 
curcumin (G-H). Light and fluorescent microscopic views of Zebrafish incubated curcumin loaded PCL nanoparticles (I-J). Light and 
fluorescent microscopic views of Zebrafish incubated with curcumin loaded MPEG-PCL nanoparticles (K-L).  
 
Accumulation of nanoparticles in the  CNS is of particular interest for brain delivery of drug. Careful analysis 
revealed that the MPEG-PCL nanoparticles accumulated in the CNS in more than PCL nanoparticles. Collectively, 
our results indicate that MPEG-PCL nanoencapsulation is highly efficient in term of  CNS uptake, which is in 
accordance with the previous report on the enhanced brain delivery of tanshinone IIA through PEGylation (Liu et 
al., 2013). 
Chapter 4                                                         In- vitro cellular uptake and in-vivo localization of nanoparticles 
 
106 
 
4.5. Conclusion 
We found that the antioxidant and neuroprotective effects of W. somnifera extract and curcumin could be 
significantly improved via nanoencapsulation. Among the two different polymers used for the nanoparticle 
preparation, MPEG-PCL promoted cellular uptake and thereby neuroprotection. In-vivo localization analysis of 
nanoparticles in Zebrafish suggests that the accumulation of MPEG-PCL nanoparticles is much higher in CNS 
compared to PCL nanoparticles. Together, our results conclude that MPEG-PCL nanoencapsulation enhances the 
cellular uptake and neuroprotection of both W. somnifera extract and curcumin. This could be a   potential 
candidate for protecting the neurons from oxidative damage. 
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5. Antimicrobial activity of cream incorporated with silver nanoparticles biosynthesized from 
Withania somnifera 
5.1 Abstract 
In the present study, we report on the antimicrobial activity of a cream formulation of silver nanoparticles (AgNPs) 
biosynthesized using W. somnifera extract. Aqueous extracts of leaves promoted efficient green synthesis of 
AgNPs compared to fruits and root extracts of W. somnifera. Biosynthesized AgNPs were characterized for their 
size and shape by physical-chemical techniques such as UV-Visible spectroscopy, Laser Doppler anemometry, 
Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM), Atomic Force Microscopy (AFM), 
X-ray diffraction (XRD) and X-ray energy dispersive spectroscopy (EDX). After confirming the antimicrobial potential 
of AgNPs, they were incorporated into a cream.  Cream formulations of AgNPs and AgNO3 were prepared and 
compared for their antimicrobial activity against human pathogens (Staphylococcus aureus, Pseudomonas 
aeruginosa, Proteus vulgarius, Escherichia coli and Candida albicans) and a plant pathogen (Agrobacterium 
tumefaciens). Our results show that AgNPs cream possess significantly higher antimicrobial activity against the 
tested organisms 
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5.2. Introduction 
Nanotechnology and nano-tools have gained much attention due to their wide range of applications in physics, 
chemistry, biology, material science and medicine (Karuppiah and Rajmohan, 2013). Metal nanoparticles like 
silver, gold, copper have been used for diagnostic and treatment of disease because of their catalytic, optical, 
electronic, antimicrobial and magnetic properties(Zayed et al., 2012). Sliver nanoparticles (AgNPs) are generally 
synthesized by physical and chemical methods such as electrochemical reduction, and thermal 
evaporation(Jagtap and Bapat, 2013; Tan et al., 2002; Devaux et al., 1993) .  But these methods are time-
consuming and difficult to scale up. Furthermore these methods are environmentally unsafe due to the use of 
toxic chemicals. A method that could avoid all the above-mentioned limitations is the ideal choice for preparing 
AgNPs. Recently, it has been shown that several plant extracts can undergo highly controlled and hierarchical 
assembly, which makes them suitable for the development of a reliable and eco-friendly process (green synthesis) 
for metal nanoparticle synthesis(Geethalakshmi and Sarada, 2013; Vijayakumar et al., 2013; Jain et al., 2009; 
Vilchis-Nestor et al., 2008; Abu Bakar et al., 2007; Gregory et al., 2014c). 
W. somnifera (L) Dunal, (solanaceae), commonly known as ashwagandha or winter cherry, is a well-known 
medicinal plant in Ayurvedic medicine. The principal active compounds include several withanolide-type 
compounds (Bhattacharya and Muruganandam, 2003; Mirjalili et al., 2009).  Due to the nontoxic and high 
medicinal value of W. somnifera, this plant is widely used all over world. Roots, and less often leaves and fruits, 
have been used as phytomedicines in the form of decoction, infusions, ointment, powder and syrup (Bhattacharya 
and Muruganandam, 2003; Mirjalili et al., 2009; Gregory et al., 2014a). Nowadays, this plant is cultivated as a 
crop to support the high demand of biomass and a sustainable quality for pharmaceutical industry needs 
(Rajaswara Rao et al., 2012)   . In this study, we biosynthesized AgNPs using W. somnifera extract and identified 
the compounds responsible for the formation of AgNPs. To demonstrate the potential pharmaceutical and 
industrial application of synthesized AgNPs, we have developed AgNPs- cream formulation and evaluated 
antimicrobial activity in a range of microorganisms.  
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5.3. Materials and Methods 
5.3.1. Preparation of W. somnifera plant extract 
W. somnifera (WS) plants were collected at Pondicherry Botanical Garden (Pondicherry, India). Leaves, fruits and 
roots were dried under shade at 25 °C and powdered.  W. somnifera  aqueous extracts (2, 4, 6 and 8 %, w/v) 
were prepared by boiling leaf, fruit and root biomass separately in 500 mL Erlenmeyer flasks containing 100 mL 
of sterile distilled water for 1 hrs. Aqueous extracts were obtained by centrifugation at 10,000 rpm for 10 min 
followed by filtration. 
5.3.2. Synthesis of silver nanoparticles (AgNPs) 
We screened several W. somnifera extracts for AgNPs formation. Firstly, 10 ml of 1mM AgNO3 solution was 
added to 500 µl aliquots of different concentrations (2, 4, 6 and 8 %, w/v)  of roots, leaves and fruits aqueous  W. 
somnifera  extracts. The reaction occurred in 25 mL volumetric flasks at room temperature, solutions were 
vortexed (5min) thrice daily and continuously monitored for color changes as an indication of AgNO3 conversion 
into AgNPs. Simultaneously, aliquots were taken and analyzed for absorbance at 300–700 nm in a UV–Vis 
spectrophotometer. After AgNPs formation, the solution was centrifuged at 20,000 rpm for 15 min and 
supernatants discarded. Nanoparticles were washed with 10 ml of deionized water, centrifuged again, and 
supernatant discarded. Finally, AgNPs were re-dispersed in 10 ml of deionized water. 
Since AgNPs were efficiently formed in 6% of aqueous leaf extract, we chose this extract for further standardization 
of AgNO3 concentration. Briefly, different concentrations of AgNO3 (0.1, 0.5, 1 and 2 m M) were prepared and 10 
ml of each concentration were added to 6% w/v of leaf extract and the nanoparticle formation was recorded. As 
the combination of 6% leaf extract and 1mM AgNO3 found to be the optimum, AgNPs synthesized with this 
combination was used in all the experiments.  
5.3.3. Physical characterization of AgNPs 
5.3.3.1. Particle size and Zeta potential analysis 
The size and zeta potential of AgNPs was determined by laser Doppler anemometry, using a Zetasizer 
(Zetasizernano ZS, Malvern Instruments, UK). Briefly, 100 L of nanoparticle was diluted to 1 ml with deionized 
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water. An electric field of 150 mV was applied to observe the electrophoretic velocity of the particles (Marslin et 
al., 2009). All measurements were made at room temperature. Three independent samples run in triplicate were 
done. 
5.3.3.2. Electron Microscopy analysis 
Morphological characterization of the AgNPs was done by TEM and SEM analysis. For the TEM analyses the 
AgNPs were negatively stained with sodium uranyl acetate 1% solution and analysed using a transmission electron 
microscopy (TEM, JEOL-1400, 902A Jeol Ltd)(Gregory et al., 2014b). For the SEM analysis samples were 
prepared by dropping nanoparticle suspension onto aluminum stubs and allowing them to air-dry. The air-dried 
particles were sputter coated with gold under vacuum by using a Fiscon Instrument SC 502 and observed by SEM 
(Leica Cambridge S 360, Cambridge) for imaging.  EDX analysis was conducted with the same instrument to 
confirm the elemental composition of the sample. 
 5.3.3.3. Atomic Force Microscopy (AFM)  
The surface morphology of the AgNPs nanoparticles was studied by atomic force microscopy (AFM). A drop of the 
AgNPs was placed onto a 2x2 mm glass slide and left until the liquid had evaporated. Images were recorded using 
tapping mode in air on a Multi-mode Nanoscope IIa instrument equipped with a J scanner (Veeco Instruments, 
Santa Barbara, USA) and silicon nanoprobes (NCHV, Veeco). All images (600 nm wide) were fitted to a plane 
using the 1 degree flatten procedure included in the NanoScope software version 4.43r8. 
5.3.3.4. X-ray diffractometry analysis 
An x-ray diffraction (XRD) study of AgNPs was performed using an X-ray diffractometer (Philips, PW1710) with a 
horizontal goniometer. The samples were placed in the sample holder and scanned at a rate of 1° min -1 from 0° to 
70°. 
5.3.4. Chemical characterization of AgNPs 
AgNPs and W. somnifera leaf aqueous extract were analysed by High Performance Liquid Chromatography with 
Diode Array Detector (HPLC-DAD) (Merck-Hitachi LaChrom Elite) (Dias et al., 1999) . Briefly, 2 mL of AgNPs were 
centrifuged and the pelleted AgNPs were extracted with 1 ml of 50% methanol. AgNPs extract solution and W. 
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somnifera leaf extract were filtered (Nylaflo membrane 0.45µM) prior to the HPLC analysis. Aliquots of these 
samples (20µL) were directly injected in HPLC. Chromatographic separations were carried out at 30 ºC, on a 
LiChrospher RP-18e column (Merck, Germany), using 0.1% acetic acid in water (solution A), and 0.1% acetic acid 
in acetonitrile (solution B) as the mobile phases, at a flow rate of 0.7 ml/min. The following gradient was used: 
from 0 to 30 min, mobile phase A was decreased from 55% to  10% A. Data was recorded in the 200-520 nm 
range, and chromatograms recorded at 235 and 350 nm. Compounds were quantified by external standards of 
catechin, p-coumaric acid luteolin-7-glucoside (Sigma-Aldrich, Barcelona, Spain) and withanolides (Natural 
Remedies, India).  
5.3.5. Antimicrobial activity studies 
5.3.5.1. Screening of AgNO3, W. somnifera leaf extract and AgNPs for antimicrobial activity  
The preliminary antibacterial potential of AgNPs and the components used in the synthesis (AgNO3 and W. 
somnifera leaf extract) was tested against E. coli by disc diffusion method. Briefly, 100 l aliquots of E. coli culture 
were spread on petri dishes containing agar solidified LB medium. Sterile paper discs (5 mm diameter) 
impregnated with equivalent concentrations of AgNPs (20 µl), W. somnifera leaf extract and AgNO3 solution were 
placed on the medium. Paper discs impregnated with water (20 µl) were used as control. The plates were 
incubated at 37 °C for 24 hrs and the inhibition zones were measured. 
5.3.5.2. AgNPs cream preparation and its antimicrobial activity 
Cream formulation with AgNPs was prepared with Croda base CR2 (EMFAL, MG, Brazil). Briefly, the CR2 was 
prepared at a concentration of 15% (w/v) in ultra-pure water (control) or containing 1% AgNO3 (AgNO3 cream) and 
equivalent AgNPs (AgNPs cream). The antimicrobial activities of the creams were evaluated by colony forming unit 
(CFU) method. Briefly, to 950 µl of grown microbial cultures (S. aureus, P. aeruginosa, C. albicans, P. vulgaris, E. 
coli, A. tumefaciens), 50 µl of cream (AgNO3, AgNPs, or empty cream) at various dilutions were added and kept in 
37 °C. Cultures added with 50 µl water served as positive control. After 24 hrs, 100 µl from each treatment and 
control were plated on LB agar medium using a sterile T- spreader. The colony forming units (CFUs) in each plate 
were counted after overnight incubation. All the experiments were done in quadruplicate. 
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5.4. Results and discussion 
5.4.1. Green synthesis of silver nanoparticles  
Among the different concentrations of W. somnifera extracts and AgNO3 used for nanoparticles synthesis, 6 % w/v 
of WS and 1 mM AgNO3 showed better reaction profiles and were selected for further studies. When AgNO3 was 
added, leaf aqueous extract changed into a reddish color Figure 1A, whereas fruit and root extracts did not change 
their color within 7 days so withdrawn from studies. UV-Vis absorbance at 430 nm confirmed the reduction of 
silver ion to metal silver by the action of aqueous leaf extract of WS (Figure 1B). It was evident that WS leaf extract 
contains compounds suitable for green synthesis whereas roots and fruits extracts were not effective. Recently, 
the photosensitized synthesis of AgNPs via W. somnifera leaf powder was reported (Raut et al., 2014). 
 
Figure 1. Photograph showing the AgNPs incorporated cream (A).  UV–Vis spectra of AgNPs synthesized using 6% w/w W. somnifera 
aqueous extract with 1mM AgNO3 at different time intervals (B), and visual observation of color changes.  
 
5.4.2. Characterization of AgNPs  
Particle size and size distribution are important characteristics of nanoparticles, as they determine their biological 
fate, toxicity, targeting ability and stability. The synthesized AgNPs had a size ranging between 70-110 nm, as 
confirmed by laser Doppler anemometry analysis (Figure 2F). The zeta potential was found to be -30.0±1.8 mv 
indicating the stability of the formulation. 
The TEM, AFM and SEM images of AgNPs correlates with DLS data and showed particles with a spherical-irregular 
appearance (Figure 2A-D). Silver nanoparticles were brighter and easily identified by backscattered light in SEM 
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images, since metals like silver have higher secondary electron emission (Figure 2C-D). EDX spectrum of 
synthesized silver nanoparticles Figure 2E clearly exhibited the presence of elemental silver metal. The sharp 
signal peak of silver confirmed the reduction of silver nitrate to silver nanoparticles. 
 
Figure 2. Morphological characterization of AgNPs. TEM images of (A), AFM height image (B) SEM primary image (C), Backscattered 
image (D), and X-ray energy dispersive spectrum   (E) of AgNPs, (F) Particle size distribution of AgNPs. 
The crystalline nature of AgNPs was confirmed by XRD analysis (Figure 3). The intensity of peaks reflects the high 
degree of crystallinity of the AgNPs. The distinct diffraction peaks at 38.06, 44.23 and 67.43 were indexed with 
planes (111) (200) (220). The well intense XRD pattern clearly showed the formation of AgNPs (JCPDS card no 
04-0783, 1991) (Amutha et al. (2014) reported the same pattern of diffraction peak at 32.16 and indexed with 
planes (101), in biosynthesized AgNPs at room temperature. In the same way we got a peak at 32.20 and 
indexed with planes (101) (Amutha et al., 2014). 
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Figure 3. XRD patterns of the synthesized AgNPs with aqueous leaf extract of W. somnifera. 
5.4.3. W. somnifera compounds responsible for green synthesis of AgNPs  
Although green synthesis of AgNPs has been reported using extracts from different plant species, the knowledge 
concerning the phytocompounds responsible for green synthesis is still lacking. It was proposed that phenolics like 
catechin, may act as a reducing, stabilizing and capping agent (Tamuly et al., 2013; Nadagouda and Varma, 
2008). 
In order to identify the W. somnifera compounds participating in green synthesis of AgNPs, we performed HPLC 
analysis. We identified several withanolides in W. somnifera leaf extract based on their characteristic UV-Vis 
spectra (Figure 4A-D; Table 1). Additionally, HPLC analysis of AgNPs revealed that some W. somnifera phenolic 
compounds were selectively trapped in the nanoparticles (Figure 4C, D). These compounds, based on their 
characteristic UV-Vis spectra, and further confirmation with co-elution with pure standards, were identified as 
catechin, p-coumaric acid and luteolin-7-glucoside (Figure 4C, D, and Table 1). These substances were masked by 
other major compounds (peaks) present in W. somnifera extract, namely withanolides. In AgNPs chromatograms 
they were noticed since they were selectively trapped in AgNPs, being the other compounds removed when we 
washed the nanoparticles. Additionally, a major compound (peak 4) was found in AgNPs but not identified in the 
original W. somnifera leaf aqueous extract. This compound has UV-Vis spectra similar to other withanolides found 
in leaf aqueous extract (peaks W2, W5 and W6) but with a different retention time and showing a bathochromic 
effect on its spectra.  
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Table 1. Retention time of the compounds present in W. somnifera aqueous leaf extract and AgNPs. 
 
 
 
 
 
 
 
Figure 4. HPLC chromatograms of aqueous leaf extract of W. somnifera and green synthesized AgNPs. HPLC chromatogram of aqueous 
leaf extract of W.somnifera recorded at 235 and 350 nm (A and B).  HPLC chromatogram of AgNPs recorded at 235 and 350 nm (C and 
D). Peaks identification is listed in Table 1. 
Taking this in consideration, this compound might be a derivative originated from the interaction of some 
withanolide with silver ions.  So we can conclude that the formation of AgNPs involved the interaction of silver ions 
Peak No 
Retention time (min) 
Compound 
Aqueous leaf extract AgNPs 
W1 4.32 - withanolide 
W2 4.82 - withanolide 
W3 5.74 - withanolide 
W4 6.82 - withanolide 
W5 9.26 - withanolide 
W6 11.94 - withanolide 
1 - 2.98 catechin 
2 - 3.29 p-coumaric acid 
3 - 4.23 luteolin-7-glucoside 
4 - 9.89 withanolide 
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with both selected phenolics and withanolides present in W. somnifera aqueous leaf extract. Recently, the 
relevance of phenolic compounds for the green synthesis of metal nanoparticles from Eucalyptus globulus bark 
was reported (Santos et al., 2014). 
5.4.4. Antimicrobial activity of AgNPs 
It is well known that a number of chemical forms of silver exhibit antimicrobial activities (Lok et al., 2006). AgNPs 
showed a wider bacterial inhibition zone than AgNO3 in all bacteria analysed (E. coli, P. aeruginosa and A. 
tumefaciens) (Figure 5 A-C).  
 
Figure 5. Anti-bacterial activity of AgNPs analyzed by disc diffusion method. Bacterial growth without treatments (1) or treated with 
equivalent amount of  W. somnifera aqueous extract (2), AgNO3 (3) and AgNPs (4).The bacteria tested were E.coli (A), P. 
aeruginosa(B), and A. tumefaciens (C). 
AgNPs interaction with E.coli cells were studied using SEM analysis (Figure 6). The AgNPs treated cells (2 hrs and 
4 hrs) showed increased disruption in the cell wall of E. coli with increase time interval.  
 
Figure 6. SEM analysis of AgNPs and E. coli interaction. Cellular interaction of AgNPs and E.coli visualized by scanning electron 
microscopy (SEM) analysis: control (A), after 2 hrs (B) and 4 hrs (C) incubation time. 
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No disruption was seen in untreated cells, clearly indicating the enhanced antibacterial activity of AgNPs (Figure 6 
A-C).  
The results from colony counting method showed that AgNPs significantly reduced the number of E.coli cells from 
106 to 1.3±0.9 CFUs, while the reduction with AgNO3 treatment was 258.6±9.9, and no reduction was observed 
with  W. somnifera aqueous extract treatment (Figure 7). These results further substantiate the higher 
antimicrobial activity (aprox. 200 times more effective) of AgNPs comparing to equivalent amounts of AgNO3. It is 
well reported that silver nanoparticles have a higher activity then AgNO3 counterparts (Velusamy et al., 2015). 
Moreover, plant extract biosynthesized silver nanoparticles showed enhanced antibacterial activity compared to 
chemically synthesize silver nanoparticles (Mukherjee et al., 2014).   
The lethality of AgNPs can occur by physical process such as damaging bacterial cellular proteins, disruption of 
cell membrane, blocking the microbial respiratory chain system and penetration of nanoparticles in to the 
cytoplasm(Dror-Ehre et al., 2009;  Zhang et al., 2008). The higher antibacterial activity of AgNPs, compared with 
AgNO3, could also be due to the presence of W. somnifera phenolics in the nanoparticles. It is well known that 
some phenolics can have antimicrobial activities or potentiate the activity of antibiotics, increasing their efficacy.  
 
Figure 7. Anti-bacterial potential of AgNPs by colony counting method. E.coli without treatment (just water) (A), E.coli treated with plant 
extract (B), E.coli treated with AgNO3 (c), and E.coli treated with AgNPs (D). 
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Compounds like flavones and cathecin derivatives, structurally similar to the ones identified in  W. somnifera and 
AgNPs, have been shown to have light antimicrobial activity  (Cushnie and Lamb, 2011; Daglia, 2012). Several tea 
catechins in combination with oxacillin (ß-lactam antibiotic) increase its activity against several strains of S. aureus 
up to 128-fold  (Daglia, 2012). Some antimicrobial mechanisms of the phenolics are related with efflux pump 
inactivation and cytoplasmic membrane destabilization(Cushnie and Lamb, 2011), which might explain the 
observed effects (SEM analysis) of AgNPs in bacterial cells Figure 6 and their higher activity compared with AgNO3 
or W. somnifera extract alone (Figure 7). 
Antibiotic creams are used to speed the healing of wounds and prevent infection. Antibacterial activity of creams 
incorporated with AgNO3 and AgNPs were compared with an empty cream, against pathogenic clinical microbial 
isolates of S. aureus, P. aeruginosa, C.albicans, P. vulgarius, E. coli, and the plant pathogen A. tumefaciens.  The 
results showed that AgNPs cream significantly reduced the number of colonies against all the tested pathogens 
compared to the cream containing AgNO3 (Table 2). These results further substantiate the higher antimicrobial 
activity against the Gram-positive bacteria S. aureus (aprox. 200 times more effective) of AgNPs-cream comparing 
to AgNO3-cream. Similarly, Gram-negative bacteria’s viz, P. aeruginosa, P. vulgarius, E. coli, and A. tumefaciens 
also showed higher reduction of CFU when treated with AgNPs (31 times, 43 times, 28 times and 13 times more, 
respectively, compared to AgNO3).  AgNPs also showed 20 time greater anti- microbial activity compared with 
AgNO3 in fungal species C. albicans. These results pointed-out AgNPs has higher antimicrobial potential against 
both Gram–positive and Gram-negative, and fungal pathogens. 
Silver-based products with antimicrobial properties are employed in different industries like medical (e.g. 
antibacterial creams), food (e.g. antibacterial agents in packaging) and in textile (e.g. preparation of silver 
wools),(Rai et al., 2009). The incorporation of silver as nanoparticles has been envisaged as an alternative 
solution, making those industries more environmental safe. The biosynthesised W. somnifera AgNPs and W. 
somnifera AgNPs-cream showed to have a strong antimicrobial activity, higher than the AgNO3 counterparts 
(Figure 7 and Table 2). Silver formulations (gels, creams, etc.) are widely used in health sector namely in wound 
care.  
Table 2: Evaluation of antimicrobial potential of AgNPs incorporated cream. 
Organisms 
Water (Control) 
(CFU) 
Empty Cream 
(CFU) 
AgNO3 in Cream 
(CFU) 
AgNPs in cream 
(CFU) 
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Stapylococcus aureus 226.3 ± 0.74 211.0± 0.69* 123.3± 0.74*** 0.6± .25***,+++ 
Pseudomonas aeruginosa 432.0 ± 0.69 408.0± 1.00* 267.6± 0.67*** 8.6± .48***,+++ 
Candida albicans 264.6± 0.88 127.6±0.75*** 33.3±0.68*** 1.6±0.25***,+++ 
Proteus vulgaris 213.0± 1.17 194.6 ± 1.02 26 .6±0.64*** 0.6±0.25***,+++ 
Escherichia coli 471.0± 1.39 441.3±1.36 226.0±1.16*** 8.0±0.66***,+++ 
Agrobacterium tumefaciens 190.3±1.47 145.3±0.88* 35.0±1.02*** 2.66±0.58***,++ 
 
Data were analyzed by non-parametric T-test using Graph Pad Prism5 software (GraphPad, USA). Data were presented as mean ± SEM 
of 4 replications. Asterisks (* P<0.05, ** P<0.01, ***P<0.001) denotes statistically significant different from water control.  Asterisks (+) 
denote statistically significant of AgNPs (+ P<0.05, ++ P<0.01, +++P<0.001) compared with different AgNO3. 
The AgNPs-cream here produced might be used for the same purposes with advantage, since it is more effective 
(antimicrobial) and so can be used in lower doses, with less toxicity for the patient and being more eco-friendly. 
5.5. Conclusion 
In conclusion, W. somnifera aqueous leaf extracts are suitable for the green synthesis of AgNPs with potent 
antimicrobial activity. Moreover, it was found that catechin, p-couparic acid, luteolin-7-glucoside and a non-
identified withanolide are compounds present in W. somnifera aqueous leaf extract responsible for green 
synthesis of AgNPs. The antimicrobial study concludes that AgNPs are 200 times more potent when compared to 
AgNO3. The AgNPs disrupt the cell membrane of E. coli as confirmed by SEM analysis. This AgNPs and cream 
incorporated AgNPs has a potential application in many different industries including medical, food and textile. 
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6. Conclusions  
During the recent years, extensive research is going on in the area of nano drug delivery of commercial drugs and 
plant bioactive compounds. However, research in the area of nanoencapsulation of extracts for targeted drug 
delivery is still at the early stage. More research should be focused on the carrier materials in order to develop 
suitable carriers, which can enhance their activity and improve the overall efficacy of plant extracts. Through 
nanotechnology, value added drug delivery systems could be developed to avail the complete therapeutic 
potentials of the herbal drugs. Thus, herbal medicine packed into polymers as nanoparticles is a successful way 
to overcome the draw backs of conventional therapies. For example poor aqueous solubility and permeability are 
two main limitations of phytomedicines, severely affecting their efficacy. In the present investigation (i) we have 
developed HPLC method for the quantification of bioactive compounds from extracts obtained from different parts 
W. somnifera and to quantify curcumin from C. longa and C. aromatica. (ii) W. somnifera extract and curcumin 
were encapsulated in PCL and MPEG-PCL nanoparticles. (iii) W. somnifera extract and curcumin loaded 
nanoparticles were characterized for their size, shape, encapsulation efficiency and drug release profile (iv) 
Characterized nanoparticles in comparison with free extract or compound were tested for their in vitro cytotoxicity, 
cellular uptake and in vitro neuroprotection in U251 glioma cells. In vivo bio localization of nanoparticles was 
analyzed in Zebrafish model. The major conclusions of the present thesis research are summarized below.  
HPLC method developed for the quantification of withanolides is new, simple, fast and reproducible. This method 
would enable the simultaneous estimation of withanolides withanolide-A, withanolide-B, withanone, withaferin-A 
and 12-deoxy-withastramonolide. We have also found that 90% methanolic extract obtained from leaf tissues 
possessed the highest amount of withanolides. Purospher. RP-18 5µm column is ideal for efficient separation of 
compounds. Regarding curcumin, we report that C. longa species has higher amount of curcumin compared to C. 
aromatica.  
Although herbal extracts possess excellent in vitro bioactivity, their poor aqueous solubility, larger molecular size 
and extensive metabolism limits their clinical outcome. Application of nanotechnology increases the bioavailability 
and bioactivity of phytomedicines by modifying their surface and reducing the size of the particles. By enabling 
targeted and sustained delivery of the drug, nanotechnology improves the pharmacokinetics profile and drug 
diffusion in various organs including crossing the BBB. In the present study, W. somnifera extract and curcumin 
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were encapsulated in PCL and MPEG-PCL nanoparticles by solvent displacement method. The sizes of the 
nanoparticles were influenced by polymer to drug ratio. The prepared nanoparticles were spherical in shape with a 
smooth surface. Importantly, nanoencapsulation greatly improved the aqueous solubility of both W. somnifera 
extract and curcumin.  
Irrespective of the loaded materials (W. somnifera and curcumin), the polymer used for encapsulation (PCL and 
MPEG-PCL) played an important role. In vitro and in vivo cellular uptake and neuroprotective effect W. somnifera 
extract and curcumin loaded MPEG-PCL nanoparticles was higher compared to their PCL formulations and free 
forms. Accordingly, both W. somnifera extract and curcumin loaded MPEG-PCL nanoparticles showed higher 
protective effect against oxidative damage induced by tBHP in U251 glioma cells. Together, our results suggest 
that MPEG-PCL nano encapsulation of W. somnifera extract /curcumin enhances their aqueous solubility and 
cellular uptake.  We believe that these formulations can be used as potential candidates for protecting the neurons 
from oxidative damage. 
Our study has also revealed that W. somnifera aqueous leaf extracts are suitable for green synthesis of silver 
nanoparticles with potent antimicrobial activity. Although there are several studies on the green synthesis of silver 
nanoparticles, the compounds responsible for this synthesis are not well known. In this context, we found that 
catechin, p-couparic acid, luteolin-7-glucoside and a non-identified withanolide are the compounds present in W. 
somnifera aqueous leaf extract are responsible for green synthesis of silver nanoparticles. From the antimicrobial 
activity assay, we could conclude that silver nanoparticles synthesized using W. somnifera extract is 200 times 
more effective compared to AgNO3. This silver nanoparticle cream formulation developed in this study would have 
potential applications in medical, food and textile industries. 
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